Annual Report to Parliament on the collection of PBS/RPBS ...
Transcript of Annual Report to Parliament on the collection of PBS/RPBS ...
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
1058
3 A
pril
2014
www.health.gov.auAll informati on in this publicati on is correct as at April 2014
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
Report to Parliament on the Collection of PBS/RPBS Under Co-payment Prescription Data 2012-13 ISBN: 978-1-74186-115-0 Online ISBN: 978-1-74186-116-7 Publications approval number: 10583 Copyright Statements: Paper-based publications © Commonwealth of Australia 2014 This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given the specific written permission from the Commonwealth to do so. Requests and inquiries concerning reproduction and rights are to be sent to the Communication Branch, Department of Health, GPO Box 9848, Canberra ACT 2601, or via e-mail to [email protected]. Internet sites © Commonwealth of Australia 2014 This work is copyright. You may download, display, print and reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given the specific written permission from the Commonwealth to do so. Requests and inquiries concerning reproduction and rights are to be sent to the Communication Branch, Department of Health, GPO Box 9848, Canberra ACT 2601, or via e-mail to [email protected].
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 1
Definitions Approved supplier an approved pharmacist, an approved medical practitioner,
or an approved hospital authority as prescribed in Section 84 of the National Health Act 1953
Community pharmacy a pharmacy business carried on, at or from, the particular
premises in respect of which a pharmacist is approved under Section 90 of the National Health Act 1953
Co-payment the amount of contribution paid by patients towards
PBS/RPBS medicines
Table 1: Co-payments for 2012-13
Date General co-payment
Concessional co-payment
1 Jan 2012 – 31 Dec 2012 $35.40 $5.80
1 Jan 2013 – 31 Dec 2013 $36.10 $5.90
Pharmacy software vendors companies responsible for maintaining desktop software on
behalf of approved suppliers Subsidised over co-payment Under co-payment a prescription that relates to an item priced below
the patient contribution as defined in the National Health Act 1953.
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 3
EXECUTIVE SUMMARY The collection of under co-payment prescription data for the Pharmaceutical Benefits Scheme (PBS) and Repatriation Pharmaceutical Benefits Scheme (RPBS) commenced on 1 April 2012. During the first full financial year of the collection, from 1 July 2012 to 30 June 2013, the Department of Human Services (DHS) processed approximately 62 million under co-payment prescriptions. This equates to 22.7% of total PBS/RPBS prescriptions, slightly higher than the anticipated volume of 20%. Data has been successfully collected from both community pharmacies and public and private hospitals. Analysis has shown that 99% of pharmacies and 94% of hospitals have submitted under co-payment prescriptions at some stage during the year. The data being collected is of a high quality, and pharmacies should be congratulated on implementing the collection so successfully. The additional data is providing the Department of Health and other researchers with enhanced coverage of medicines that are approved and dispensed under the PBS/RPBS. It is improving the accuracy of information available to the Pharmaceutical Benefits Advisory Committee (PBAC) and others to support decision making and policy formulation.
4 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
BACKGROUND
Legislation
The collection of PBS/RPBS under co-payment prescription data was agreed to under the Fifth Community Pharmacy Agreement (5CPA), and announced in the 2010-11 Budget. Legislation enabling the data to be collected is provided for in the National Health Amendment (Pharmaceutical Benefits Scheme) Act 2010 (the Amendment Bill). Supporting legislative instruments, made by the then Department of Health and Ageing and the Department of Veterans’ Affairs, were registered on the Federal Register of Legislative Instruments prior to 1 April 2012. On 22 November 2010 as part of the second reading motion of the Amendment Bill in the Senate, Senator Siewert moved a second reading amendment in relation to the second reading motion for the National Health Amendment (Pharmaceutical Benefits Scheme) Bill 2010 which stated that: '...the Senate calls on the Government:
(a) to ensure that there is an annual report to Parliament on all available data on under co-payment products, including the drug name and form, the quantities dispensed;...'.
Hansard from the Senate indicates that this second reading amendment was agreed to (page 1799). Data collection
As agreed under the 5CPA, the data being collected includes: • the patient’s name; • the patient’s Medicare Number; • information about the prescription (including the date of prescribing and supply, the
PBS code number, the drug name and form, the quantity dispensed and the number of repeats);
• the prescriber approval number; and • the approved supplier name.
Pricing information is not being collected. Approved suppliers go through similar steps when processing both subsidised and under co-payment prescriptions, using pharmaceutical dispensing software programmes. In providing under co-payment data pharmacists are not performing any additional work, apart from validation of essential information such as prescription dates, pharmacy identification, patient eligibility and medication details.
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 5
Funding of $2.9 million was provided in the 2010-11 Budget to assist pharmacy software vendors to make a number of changes to pharmacy IT systems relating to 5CPA programs, including changes to allow under co-payment data collection. Under co-payment data is being collected and disclosed in accordance with the Privacy Act 1988 and the secrecy provisions of the National Health Act 1953. The Office of the Information Commissioner has been advised of this. Both the Pharmacy Guild of Australia and the Department of Human Services have confirmed that no significant issues have been reported since the collection commenced. There were some initial difficulties with dispensing software at a small number of pharmacies and hospitals but these issues were resolved prior to 1 July 2012. Table 2: Under co-payment prescriptions 2012-13 (by date of processing)
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
ACAMPROSATE Tablet (enteric coated) containing acamprosate calcium 333 mg 15 15
ACARBOSE Tablet 100 mg 1 1 ACARBOSE Tablet 50 mg 4,565 4,565 ACETAZOLAMIDE Tablet 250 mg 14,276 7 14,283 ACICLOVIR Eye ointment 30 mg per g, 4.5 g 13,092 13,092 ACICLOVIR Tablet 200 mg 40 40 ACICLOVIR Tablet 800 mg 3 3 ACITRETIN Capsule 10 mg 1 1
ADAPALENE + BENZOYL PEROXIDE Gel 1 mg-25 mg per g, 30 g 419 419
ADRENALINE I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector (EpiPen Jr.)
1 1
ADRENALINE Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) 513 513
ALBENDAZOLE Tablet 200 mg 973 973 ALBENDAZOLE Tablet 400 mg 9 9
ALENDRONATE Tablet 70 mg (as alendronate sodium) 45,429 8 45,437
ALENDRONATE + COLECALCIFEROL
Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol
16 16
ALENDRONATE + COLECALCIFEROL
Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol
5 5
6 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
ALENDRONATE + COLECALCIFEROL (&) CALCIUM CARBONATE
Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate)
5 5
ALGINATE SODIUM + CALCIUM CARBONATE + BICARBONATE
Oral liquid containing alginic acid as sodium alginate 1 g, calcium carbonate 320 mg and sodium bi-carbonate 534 mg in 20 mL, 500 mL
3,605 2 3,607
ALLOPURINOL Tablet 100 mg 90,404 144 90,548 ALLOPURINOL Tablet 300 mg 303,256 117 303,373 ALPRAZOLAM Tablet 1 mg 36,034 1 36,035 ALPRAZOLAM Tablet 2 mg 18,086 18,086 ALPRAZOLAM Tablet 250 micrograms 14,125 11 14,136 ALPRAZOLAM Tablet 500 micrograms 31,926 10 31,936 ALUMINIUM ACETATE Ear drop 15mL 45 45 ALUMINIUM ACETATE Ltn 200mL 99 99 ALUMINIUM HYDROXIDE DRIED + MAGNESIUM TRISILICATE + MAGNESIUM HYDROXIDE
Oral suspension 250 mg-120 mg-120 mg per 5 mL, 500 mL 1,015 10 1,025
ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE
Oral suspension 200 mg-200 mg per 5 mL, 500 mL 2,938 14 2,952
ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE and SIMETHICONE
Tablet 400 mg-400 mg-40 mg 1 1
AMANTADINE Capsule containing amantadine hydrochloride 100 mg 53 53
AMIODARONE Tablet containing amiodarone hydrochloride 100 mg 8,853 16 8,869
AMIODARONE Tablet containing amiodarone hydrochloride 200 mg 36,192 12 36,204
AMISULPRIDE Tablet 100 mg 2,809 2,809 AMISULPRIDE Tablet 200 mg 34 34 AMISULPRIDE Tablet 400 mg 16 16
AMITRIPTYLINE Tablet containing amitriptyline hydrochloride 10 mg 207,237 88 207,325
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 7
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
AMITRIPTYLINE Tablet containing amitriptyline hydrochloride 25 mg 176,000 58 176,058
AMITRIPTYLINE Tablet containing amitriptyline hydrochloride 50 mg 125,370 32 125,402
AMLODIPINE Tablet 10 mg (as besylate) 308,156 28 308,184 AMLODIPINE Tablet 10 mg (as maleate) 27,977 27,977 AMLODIPINE Tablet 5 mg (as besylate) 366,863 238 367,101 AMLODIPINE Tablet 5 mg (as maleate) 34,456 1 34,457
AMLODIPINE + ATORVASTATIN
Tablet 10 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium)
2 2
AMLODIPINE + ATORVASTATIN
Tablet 10 mg amlodipine (as besylate) with 20 mg atorvastatin (as calcium)
5 5
AMLODIPINE + ATORVASTATIN
Tablet 10 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium)
1 1
AMLODIPINE + ATORVASTATIN
Tablet 5 mg amlodipine (as besylate) with 10 mg atorvastatin (as calcium)
2 2
AMLODIPINE + ATORVASTATIN
Tablet 5 mg amlodipine (as besylate) with 40 mg atorvastatin (as calcium)
3 3
AMLODIPINE + ATORVASTATIN
Tablet 5 mg amlodipine (as besylate) with 80 mg atorvastatin (as calcium)
2 2
AMLODIPINE + PERINDOPRIL
Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)
696 696
AMLODIPINE + PERINDOPRIL
Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)
154,014 154,014
AMLODIPINE + PERINDOPRIL
Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate)
23,207 23,207
AMLODIPINE + PERINDOPRIL
Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)
95,557 95,557
AMLODIPINE + VALSARTAN Tablet 10 mg (as besylate)-160 mg 51,335 51,335 AMLODIPINE + VALSARTAN Tablet 10 mg (as besylate)-320 mg 11,366 11,366 AMLODIPINE + VALSARTAN Tablet 5 mg (as besylate)-160 mg 53,164 53,164
8 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
AMLODIPINE + VALSARTAN Tablet 5 mg (as besylate)-320 mg 14,384 14,384 AMLODIPINE + VALSARTAN Tablet 5 mg (as besylate)-80 mg 27,306 27,306
AMLODIPINE + VALSARTAN + HYDROCHLOROTHIAZIDE
Tablet 10 mg (as besylate)-160 mg-12.5 mg 28,532 28,532
AMLODIPINE + VALSARTAN + HYDROCHLOROTHIAZIDE
Tablet 10 mg (as besylate)-160 mg-25 mg 6,226 6,226
AMLODIPINE + VALSARTAN + HYDROCHLOROTHIAZIDE
Tablet 10 mg (as besylate)-320 mg-25 mg 13,662 13,662
AMLODIPINE + VALSARTAN + HYDROCHLOROTHIAZIDE
Tablet 5 mg (as besylate)-160 mg-12.5 mg 30,614 30,614
AMLODIPINE + VALSARTAN + HYDROCHLOROTHIAZIDE
Tablet 5 mg (as besylate)-160 mg-25 mg 9,439 9,439
AMMONIUM + SENEGA ROOT Mixture 200 mL 9 9
AMOXYCILLIN Capsule 250 mg (as trihydrate) 168,629 39 168,668 AMOXYCILLIN Capsule 500 mg (as trihydrate) 1,995,347 375 1,995,722
AMOXYCILLIN Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL
321,584 321,584
AMOXYCILLIN Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL
603,496 603,496
AMOXYCILLIN Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL
24,548 24,548
AMOXYCILLIN Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL
119,856 119,856
AMOXYCILLIN Sachet containing oral powder 3 g (as trihydrate) 53 53
AMOXYCILLIN Tablet 1 g (as trihydrate) 43,535 9 43,544
AMOXYCILLIN + CLAVULANIC ACID
Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
48,421 48,421
AMOXYCILLIN + CLAVULANIC ACID
Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
276,403 46 276,449
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 9
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
AMOXYCILLIN + CLAVULANIC ACID
Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
267,350 127 267,477
AMOXYCILLIN + CLAVULANIC ACID
Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
1,812,348 1,043 1,813,391
AMPHOTERICIN B Lozenge 10 mg 42,572 15 42,587
AMPICILLIN Powder for injection 1g (as sodium) 3,376 3,376
AMPICILLIN Powder for injection 500 mg (as sodium) 96 96
ANASTROZOLE Tablet 1 mg 6 6
APRACLONIDINE Eye drops 5 mg (as hydrochloride) per mL, 10 mL 30 30
ARIPIPRAZOLE Tablet 10 mg 25 25 ARIPIPRAZOLE Tablet 15 mg 4 4
ARTEMETHER + LUMEFANTRINE Tablet 20 mg-120 mg 13 13
ASENAPINE Sublingual wafer 10mg (as maleate) 2 2
ASENAPINE Sublingual wafer 5 mg (as maleate) 17 17 ASPIRIN Tablet 100 mg 84,535 1,083 85,618 ASPIRIN Tablet 100 mg (enteric coated) 20 20 ASPIRIN Tablet 100 mg (with glycine) 1 1 ASPIRIN Tablet, dispersible, 300 mg 6,160 47 6,207
ASPIRIN + CLOPIDOGREL Tablet 75 mg (as hydrogen sulfate)-100 mg 30 30
ATENOLOL Oral solution 50 mg in 10 mL, 300 mL 64 64
ATENOLOL Tablet 50 mg 959,721 710 960,431 ATOMOXETINE Capsule 10 mg (as hydrochloride) 1 1 ATOMOXETINE Capsule 40 mg (as hydrochloride) 1 1 ATORVASTATIN Tablet 10 mg (as calcium) 170,975 9 170,984 ATORVASTATIN Tablet 20 mg (as calcium) 4,946 3 4,949 ATORVASTATIN Tablet 40 mg (as calcium) 254 3 257 ATORVASTATIN Tablet 80 mg (as calcium) 91 1 92
10 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
ATOVAQUONE + PROGUANIL
Tablet containing atovaquone 250 mg with proguanil hydrochloride 100 mg
1 1
ATROPINE Eye drops containing atropine sulfate 10 mg per mL, 15 mL 5,334 5,334
ATROPINE Injection containing atropine sulfate 600 micrograms in 1 mL 363 363
AUROTHIOMALATE SODIUM
Injection containing sodium aurothiomalate 50 mg 1 1
AZATHIOPRINE Tablet 25 mg 7,651 7,651 AZATHIOPRINE Tablet 50 mg 284 2 286
AZITHROMYCIN Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL 5,912 5,912
AZITHROMYCIN Tablet 500 mg (as dihydrate) 82,110 82,110 AZITHROMYCIN Tablet 600 mg (as dihydrate) 1 1 BACLOFEN Tablet 10 mg 22,183 22,183 BACLOFEN Tablet 25 mg 95 95
BALSALAZIDE Capsule containing balsalazide sodium 750 mg 2 2
BECLOMETHASONE
Pressurised inhalation containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation)
17,243 17,243
BECLOMETHASONE
Pressurised inhalation containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation)
3,880 3,880
BECLOMETHASONE
Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 100 micrograms per dose, 200 doses (CFC-free formulation)
7 7
BECLOMETHASONE
Pressurised inhalation in breath actuated device containing beclomethasone dipropionate 50 micrograms per dose, 200 doses (CFC-free formulation)
495 495
BENZATHINE BENZYLPENICILLIN
Injection 900 mg in 2.3 mL single use pre-filled syringe 9 9
BENZHEXOL Tablet containing benzhexol hydrochloride 2 mg 1,465 1,465
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 11
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
BENZHEXOL Tablet containing benzhexol hydrochloride 5 mg 352 352
BENZOIN with MENTHOL Inhal 1 2 2
BENZTROPINE Tablet containing benztropine mesylate 2 mg 6,708 9 6,717
BENZYDAMINE Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL
456 456
BENZYLPENICILLIN Powder for injection 3g (as sodium) 144 144
BENZYLPENICILLIN Powder for injection 600 mg (as sodium) 1,300 1,300
BETAMETHASONE ACETATE + BETAMETHASONE SODIUM PHOSPHATE
Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL
14,355 14,355
BETAMETHASONE DIPROPIONATE
Cream 500 micrograms (as dipropionate) per g, 15 g 117,395 117,395
BETAMETHASONE DIPROPIONATE
Ointment 500 micrograms (as dipropionate) per g, 15 g 87,003 87,003
BETAMETHASONE DIPROPIONATE + CALCIPOTRIOL
Gel containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g
5 5
BETAMETHASONE DIPROPIONATE + CALCIPOTRIOL
Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g
78 78
BETAMETHASONE VALERATE
Cream 200 micrograms (as valerate) per g, 100 g 145,564 145,564
BETAMETHASONE VALERATE
Cream 500 micrograms (as valerate) per g, 15 g 30,671 17 30,688
BETAMETHASONE VALERATE
Ointment 200 micrograms (as valerate) per g, 100 g 22,870 22,870
BETAMETHASONE VALERATE
Ointment 500 micrograms (as valerate) per g, 15 g 3,900 3,900
BETAXOLOL Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL 2,448 2,448
BETAXOLOL Eye drops, suspension, 2.5 mg (as hydrochloride) per mL, 5 mL 5,413 5,413
BETHANECHOL Tablet containing bethanechol hydrochloride 10 mg 535 535
12 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
BICALUTAMIDE Tablet 50 mg 2 2 BICARBONATE Capsule 840 mg 5,518 11 5,529
BIMATOPROST Eye drops 300 micrograms per mL, 3 mL 38 38
BIPERIDEN Tablet containing biperiden hydrochloride 2 mg 967 967
BISACODYL Enemas 10 mg in 5 mL, 25 15 15 BISACODYL Suppositories 10 mg, 10 1,110 1,110 BISACODYL Suppositories 10 mg, 12 232 2 234 BISACODYL Tablet 5 mg 1,087 4 1,091
BISOPROLOL Tablet containing bisoprolol fumarate 10 mg 9 9
BISOPROLOL Tablet containing bisoprolol fumarate 2.5 mg 894 7 901
BISOPROLOL Tablet containing bisoprolol fumarate 5 mg 17 17
BOCEPREVIR Capsule 200 mg 1 1
BRIMONIDINE Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL 18,120 18,120
BRIMONIDINE Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL 16,377 16,377
BRIMONIDINE + TIMOLOL Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL
22,654 22,654
BRINZOLAMIDE Eye drops 10 mg per mL, 5 mL 34,765 34,765
BRINZOLAMIDE + TIMOLOL Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL
9,769 9,769
BROMOCRIPTINE Capsule 5 mg (as mesylate) 4 4 BROMOCRIPTINE Tablet 2.5 mg (as mesylate) 4,757 4,757
BUDESONIDE Nebuliser suspension 1 mg in 2 mL single dose units, 30 1 1
BUDESONIDE Nebuliser suspension 500 micrograms in 2 mL single dose units, 30
22 22
BUDESONIDE Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses
3,101 3,101
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
BUDESONIDE Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses
23,601 23,601
BUDESONIDE Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses
7 7
BUPRENORPHINE Transdermal patch 10 mg 442 442 BUPRENORPHINE Transdermal patch 20 mg 12 12 BUPRENORPHINE Transdermal patch 5 mg 27,330 27,330 BUSULFAN Tablet 2 mg 6 6 CABERGOLINE Tablet 1 mg 210 210 CABERGOLINE Tablet 2 mg 3 3 CABERGOLINE Tablet 500 micrograms 1,932 1,932
CALCIPOTRIOL Cream 50 micrograms (as monohydrate) per g, 30 g 11,521 11,521
CALCIPOTRIOL Scalp solution 50 micrograms (as monohydrate) per mL, 30 mL 1,446 1,446
CALCITRIOL Capsule 0.25 microgram 1,382 2 1,384 CALCIUM Tablet 600 mg (as carbonate) 582 21 603
CALCIUM Tablet, chewable, 500 mg (as carbonate) 828 1 829
CANDESARTAN Tablet containing candesartan cilexetil 16 mg 356,773 3 356,776
CANDESARTAN Tablet containing candesartan cilexetil 32 mg 25,610 25,610
CANDESARTAN Tablet containing candesartan cilexetil 4 mg 83,502 79 83,581
CANDESARTAN Tablet containing candesartan cilexetil 8 mg 287,824 5 287,829
CANDESARTAN + HYDROCHLOROTHIAZIDE
Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg
260,559 260,559
CANDESARTAN + HYDROCHLOROTHIAZIDE
Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg
14,289 14,289
CANDESARTAN + HYDROCHLOROTHIAZIDE
Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg
7,581 7,581
CAPTOPRIL Tablet 12.5 mg 506 506 CAPTOPRIL Tablet 25 mg 1,747 1,747
14 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
CAPTOPRIL Tablet 50 mg 2,392 2,392
CARBAMAZEPINE Oral suspension 100 mg per 5 mL, 300 mL 3,118 3,118
CARBAMAZEPINE Tablet 100 mg 10,153 4 10,157 CARBAMAZEPINE Tablet 200 mg 30,465 3 30,468 CARBAMAZEPINE Tablet 200 mg (controlled release) 24,888 1 24,889 CARBAMAZEPINE Tablet 400 mg (controlled release) 117 117 CARBIMAZOLE Tablet 5 mg 48,317 1 48,318
CARBOMER + TRIGLYCERIDE LIPIDS Eye gel 2 mg-10 mg per g, 10 g 105 105
CARBOMER + TRIGLYCERIDE LIPIDS
Eye gel 2 mg-10 mg per g, single dose units 0.6 g, 30 1 1
CARBOMER-974 Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30 86 86
CARBOMER-980 Eye gel 2 mg per g, 10 g 2,854 5 2,859
CARBOMER-980 Eye gel 2 mg per g, single dose units 0.6 mL, 30 4 4
CARBOMER-980 + HYPROMELLOSE
Ocular lubricating gel 3 mg-2 mg per g, 10 g 4,753 21 4,774
CARMELLOSE SODIUM + GLYCEROL
Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, 15 mL
2,717 21 2,738
CARMELLOSE SODIUM + GLYCEROL
Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, single dose units 0.4 mL, 30
32 32
CARVEDILOL Tablet 12.5 mg 151 1 152 CARVEDILOL Tablet 25 mg 27 27 CARVEDILOL Tablet 3.125 mg 2,250 12 2,262 CARVEDILOL Tablet 6.25 mg 274 274
CEFACLOR Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL
51,850 51,850
CEFACLOR Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL
113,887 113,887
CEFACLOR Tablet (sustained release) 375 mg (as monohydrate) 251,566 11 251,577
CEFEPIME Powder for injection 1 g (as hydrochloride) 3 3
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 15
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
CEFOTAXIME Powder for injection 1 g (as sodium) 824 824
CEFOTAXIME Powder for injection 2 g (as sodium) 28 28
CEFTRIAXONE Powder for injection 1 g (as sodium) 7,938 2 7,940
CEFTRIAXONE Powder for injection 2 g (as sodium) 349 349
CEFTRIAXONE Powder for injection 500 mg (as sodium) 2,336 2,336
CEFUROXIME Powder for oral suspension 125 mg (as axetil) per 5 mL, 70 mL 407 407
CEFUROXIME Tablet 250 mg (as axetil) 46,953 1 46,954 CELECOXIB Capsule 100 mg 82,111 10 82,121 CELECOXIB Capsule 200 mg 381,834 3 381,837 CEPHALEXIN Capsule 250 mg (anhydrous) 126,398 84 126,482 CEPHALEXIN Capsule 500 mg (anhydrous) 1,994,152 691 1,994,843
CEPHALEXIN Granules for oral suspension 125 mg per 5 mL, 100 mL 97,847 97,847
CEPHALEXIN Granules for oral suspension 250 mg per 5 mL, 100 mL 277,588 8 277,596
CEPHALOTHIN Powder for injection 1g (as sodium) 9,280 9,280
CEPHAZOLIN Powder for injection 1g (as sodium) 12,119 12,119
CEPHAZOLIN Powder for injection 2g (as sodium) 74 74
CEPHAZOLIN Powder for injection 500 mg (as sodium) 8 8
CHLORAMBUCIL Tablet 2 mg 4 4
CHLORAMPHENICOL Ear drops (aqueous) 5 mg per mL, 5 mL 6,944 6,944
CHLORAMPHENICOL Eye drops 5 mg per mL, 10 mL 365,559 250 365,809 CHLORAMPHENICOL Eye ointment 10 mg per g, 4 g 186,423 77 186,500
CHLORPROMAZINE Injection containing chlorpromazine hydrochloride 50 mg in 2 mL
143 143
CHLORPROMAZINE Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL
378 378
16 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
CHLORPROMAZINE Tablet containing chlorpromazine hydrochloride 10 mg 1,835 1,835
CHLORPROMAZINE Tablet containing chlorpromazine hydrochloride 100 mg 2,330 2 2,332
CHLORPROMAZINE Tablet containing chlorpromazine hydrochloride 25 mg 5,317 5,317
CHLORTHALIDONE Tablet 25 mg 6,220 1 6,221
CHOLESTYRAMINE Sachets containing 4.7 g oral powder (equivalent to 4 g cholestyramine), 50
35 35
CICLESONIDE Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation)
43 43
CICLESONIDE Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation)
6,576 6,576
CIMETIDINE Tablet 400 mg 2,431 2,431 CIMETIDINE Tablet 800 mg 83 83
CIPROFLOXACIN Ear drops 3 mg (as hydrochloride) per mL, 5 mL 5,700 5,700
CIPROFLOXACIN Eye drops 3 mg (as hydrochloride) per mL, 5 mL 2,294 2,294
CIPROFLOXACIN Tablet 250 mg (as hydrochloride) 2,560 2 2,562 CIPROFLOXACIN Tablet 500 mg (as hydrochloride) 23,175 23,175 CIPROFLOXACIN Tablet 750 mg (as hydrochloride) 426 426 CITALOPRAM Tablet 10 mg (as hydrobromide) 29,383 10 29,393 CITALOPRAM Tablet 20 mg (as hydrobromide) 546,374 28 546,402 CITALOPRAM Tablet 40 mg (as hydrobromide) 73,757 73,757
CLARITHROMYCIN Powder for oral liquid 250 mg per 5 mL, 50 mL 27,335 27,335
CLARITHROMYCIN Tablet 250 mg 523,839 5 523,844 CLARITHROMYCIN Tablet 500 mg 73 73 CLINDAMYCIN Capsule 150 mg (as hydrochloride) 79,036 3 79,039
CLOMIPHENE Tablet containing clomiphene citrate 50 mg 32,242 32,242
CLOMIPRAMINE Tablet containing clomipramine hydrochloride 25 mg 16,499 16,499
CLONAZEPAM Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent)
361 361
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 17
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
CLONAZEPAM Oral liquid 2.5 mg per mL, 10 mL 822 4 826 CLONAZEPAM Tablet 2 mg 1,953 1,953 CLONAZEPAM Tablet 500 micrograms 3,835 3,835
CLONIDINE Tablet containing clonidine hydrochloride 100 micrograms 27,116 1 27,117
CLONIDINE Tablet containing clonidine hydrochloride 150 micrograms 298 298
CLOPIDOGREL Tablet 75 mg 1 1 CLOPIDOGREL Tablet 75 mg (as besilate) 3 3 CLOPIDOGREL Tablet 75 mg (as hydrogen sulfate) 157 3 160 CLOTRIMAZOLE Cream 10 mg per g, 20 g 79 79 CLOZAPINE Tablet 100 mg 205 205 CLOZAPINE Tablet 200 mg 119 119 CLOZAPINE Tablet 25 mg 765 765 CLOZAPINE Tablet 50 mg 412 412 COAL TAR PREPARED Gel 10 mg per g, 100 mL 654 654 CODEINE Codeine linct 100mL 56,043 56,043
CODEINE Tablet containing codeine phosphate 30 mg 11,706 4 11,710
COLCHICINE Tablet 500 micrograms 170,210 59 170,269
CORTISONE Tablet containing cortisone acetate 25 mg 10,902 2 10,904
CORTISONE Tablet containing cortisone acetate 5 mg 2,733 2,733
CROMOGLYCATE
Capsule containing powder for oral inhalation containing sodium cromoglycate 20 mg (for use in Intal Spinhaler or Intal Halermatic)
600 600
CROMOGLYCATE Eye drops containing sodium cromoglycate 20 mg per mL, 10 mL 8,107 8,107
CROMOGLYCATE
Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses (CFC-free formulation)
1,558 1,558
CROMOGLYCATE
Pressurised inhalation containing sodium cromoglycate 5 mg per dose, 112 doses (CFC-free formulation)
2,837 2,837
CYCLOPHOSPHAMIDE Tablet 50 mg 3,349 4 3,353 CYCLOSPORIN Capsule 10 mg 3 3
18 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
CYCLOSPORIN Capsule 25 mg 1 1 CYCLOSPORIN Capsule 50 mg 1 1
CYPROHEPTADINE Tablet containing cyproheptadine hydrochloride 4 mg (anhydrous) 9,299 2 9,301
CYPROTERONE Tablet containing cyproterone acetate 100 mg 2 2
CYPROTERONE Tablet containing cyproterone acetate 50 mg 1,159 1,159
DABIGATRAN Capsule 110 mg (as mesilate) 4 4
DALTEPARIN SODIUM Injection containing dalteparin sodium 10,000 I.U. (anti-Xa) in 1 mL single dose pre-filled syringe
7 7
DALTEPARIN SODIUM Injection containing dalteparin sodium 12,500 I.U. (anti-Xa) in 0.5 mL single dose pre-filled syringe
4 4
DALTEPARIN SODIUM Injection containing dalteparin sodium 2,500 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe
69 69
DALTEPARIN SODIUM Injection containing dalteparin sodium 5,000 I.U. (anti-Xa) in 0.2 mL single dose pre-filled syringe
118 118
DALTEPARIN SODIUM Injection containing dalteparin sodium 7,500 I.U. (anti-Xa) in 0.75 mL single dose pre-filled syringe
2 2
DANAZOL Capsule 200 mg 2 2
DANTROLENE Capsule containing dantrolene sodium 25 mg 2 2
DAPSONE Tablet 100 mg 40 40 DAPSONE Tablet 25 mg 1 1 DESMOPRESSIN Wafer 240 micrograms (as acetate) 2 2
DESVENLAFAXINE Tablet (extended release) 100 mg (as succinate) 162 1 163
DESVENLAFAXINE Tablet (extended release) 50 mg (as succinate) 457 457
DEXAMETHASONE Eye drops 1 mg per mL, 5 mL 69,631 148 69,779 DEXAMETHASONE Tablet 4 mg 64,487 241 64,728 DEXAMETHASONE Tablet 500 micrograms 12,156 17 12,173
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 19
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
DEXAMETHASONE + FRAMYCETIN SULFATE + GRAMICIDIN
Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL
277,841 14 277,855
DEXAMETHASONE SODIUM PHOSPHATE
Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL
7,590 7,590
DEXAMETHASONE SODIUM PHOSPHATE
Injection containing dexamethasone sodium phosphate equivalent to 8 mg dexamethasone phosphate in 2 mL
7,774 7,774
DEXAMPHETAMINE Tablet containing dexamphetamine sulfate 5 mg 87,831 87,831
DEXTRAN-70 + HYPROMELLOSE
Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28
5,898 5,898
DEXTRAN-70 + HYPROMELLOSE
Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL
7,361 55 7,416
DIAZEPAM Injection 10 mg in 2 mL 316 316 DIAZEPAM Tablet 2 mg 97,813 21 97,834 DIAZEPAM Tablet 5 mg 448,531 158 448,689
DICLOFENAC Suppository containing diclofenac sodium 100 mg 5,069 5,069
DICLOFENAC Tablet (enteric coated) containing diclofenac sodium 25 mg 29,884 5 29,889
DICLOFENAC Tablet (enteric coated) containing diclofenac sodium 50 mg 405,120 31 405,151
DICLOXACILLIN Capsule 250 mg (as sodium) 8,304 2 8,306 DICLOXACILLIN Capsule 500 mg (as sodium) 129,976 3 129,979
DIGOXIN Paediatric oral solution 50 micrograms per mL, 60 mL 39 39
DIGOXIN Tablet 250 micrograms 24,152 18 24,170 DIGOXIN Tablet 62.5 micrograms 25,779 316 26,095
DIHYDROERGOTAMINE Injection containing dihydroergotamine mesylate 1 mg in 1 mL
145 145
20 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
DILTIAZEM Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg
83,555 2 83,557
DILTIAZEM Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg
72,927 2 72,929
DILTIAZEM Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg
57,245 1 57,246
DILTIAZEM Tablet containing diltiazem hydrochloride 60 mg 6,946 2 6,948
DIPHENOXYLATE + ATROPINE SULFATE
Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate 25 micrograms
50,112 6 50,118
DIPHTHERIA TOXOID + TETANUS TOXOID
Injection 0.5 mL in pre-filled syringe 2,150 2,150
DIPYRIDAMOLE Capsule 200 mg (sustained release) 91 91
DIPYRIDAMOLE + ASPIRIN Capsule 200 mg (sustained release)-25 mg 1,139 6 1,145
DISOPYRAMIDE Capsule 100 mg 697 697 DISOPYRAMIDE Capsule 150 mg 1 1 DOCUSATE Tablet 50 mg 12 12
DOCUSATE + SENNOSIDE B Tablet containing docusate sodium 50 mg with sennoside B 8 mg 4 4
DOCUSATE + SENNOSIDES Tablet containing docusate sodium 50 mg with sennosides 11.27 mg 346 346
DOMPERIDONE Tablet 10 mg 62,787 48 62,835
DONEPEZIL Tablet containing donepezil hydrochloride 10 mg 1 1
DORZOLAMIDE Eye drops 20 mg (as hydrochloride) per mL, 5 mL 7,458 7,458
DORZOLAMIDE + TIMOLOL
Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL
24,107 24,107
DOTHIEPIN Capsule containing dothiepin hydrochloride 25 mg 49,265 18 49,283
DOTHIEPIN Tablet containing dothiepin hydrochloride 75 mg 75,170 46 75,216
DOXEPIN Capsule 10 mg (as hydrochloride) 14,115 4 14,119 DOXEPIN Capsule 25 mg (as hydrochloride) 17,176 14 17,190
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 21
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
DOXEPIN Tablet 50 mg (as hydrochloride) 16,549 6 16,555
DOXYCYCLINE Capsule 100 mg (as hydrochloride) (containing enteric coated pellets) 158,916 90 159,006
DOXYCYCLINE Capsule 50 mg (as hydrochloride) (containing enteric coated pellets) 167,790 28 167,818
DOXYCYCLINE Tablet 100 mg (as hydrochloride) 140,229 387 140,616 DOXYCYCLINE Tablet 100 mg (as monohydrate) 132,134 189 132,323 DOXYCYCLINE Tablet 50 mg (as hydrochloride) 144,768 77 144,845 DOXYCYCLINE Tablet 50 mg (as monohydrate) 176,893 16 176,909 DULOXETINE Capsule 30 mg (as hydrochloride) 12,271 1 12,272 DULOXETINE Capsule 60 mg (as hydrochloride) 197 197 DUTASTERIDE Capsule 500 micrograms 5,816 5,816
DUTASTERIDE + TAMSULOSIN
Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms
45,469 45,469
EFORMOTEROL
Capsule containing powder for oral inhalation containing eformoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer)
14 14
EFORMOTEROL
Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses
121 121
EFORMOTEROL
Powder for oral inhalation in breath actuated device containing eformoterol fumarate dihydrate 6 micrograms per dose, 60 doses
2,048 2,048
ELETRIPTAN Tablet 40 mg (as hydrobromide) 27,277 27,277 ELETRIPTAN Tablet 80 mg (as hydrobromide) 12,441 12,441
ENALAPRIL Tablet containing enalapril maleate 10 mg 31,807 31,807
ENALAPRIL Tablet containing enalapril maleate 20 mg 51,568 51,568
ENALAPRIL Tablet containing enalapril maleate 5 mg 15,739 21 15,760
ENALAPRIL + HYDROCHLOROTHIAZIDE
Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg
28,112 28,112
ENOXAPARIN SODIUM Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe
276 276
22 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
ENOXAPARIN SODIUM Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe
1,047 1,047
ENOXAPARIN SODIUM Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe
2,915 2 2,917
ENOXAPARIN SODIUM Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe
192 192
ENOXAPARIN SODIUM Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe
239 239
ENOXAPARIN SODIUM Solution for injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL
113 113
ENTACAPONE Tablet 200 mg 2 2
EPOETIN ALFA Injection 1,000 units in 0.5 mL pre-filled syringe 1 1
EPROSARTAN Tablet 400 mg (as mesylate) 3,736 3,736 EPROSARTAN Tablet 600 mg (as mesylate) 13,127 1 13,128
EPROSARTAN + HYDROCHLOROTHIAZIDE
Tablet 600 mg eprosartan (as mesylate) with 12.5 mg hydrochlorothiazide
20,867 20,867
ERYTHROMYCIN Capsule 250 mg (containing enteric coated pellets) 76,190 2 76,192
ERYTHROMYCIN ETHYLSUCCINATE
Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL 94,460 94,460
ERYTHROMYCIN ETHYLSUCCINATE
Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL 98,155 98,155
ERYTHROMYCIN ETHYLSUCCINATE Tablet 400 mg (as ethyl succinate) 248,108 1 248,109
ERYTHROMYCIN LACTOBIONATE
Powder for I.V. infusion 1 g (as lactobionate) 18 18
ESCITALOPRAM Oral solution 10 mg (as oxalate) per mL, 28 mL 1,731 1,731
ESCITALOPRAM Tablet 10 mg (as oxalate) 718,626 14 718,640 ESCITALOPRAM Tablet 20 mg (as oxalate) 628,406 2 628,408
ESOMEPRAZOLE Tablet (enteric coated) 20 mg (as magnesium trihydrate) 1,315,326 23 1,315,349
ESOMEPRAZOLE Tablet (enteric coated) 40 mg (as magnesium trihydrate) 2,906 3 2,909
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 23
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
ETHINYLOESTRADIOL + NORETHISTERONE
Pack containing 12 tablets 500 micrograms-35 micrograms, 9 tablets 1 mg-35 micrograms and 7 inert tablets
2,009 2,009
ETHINYLOESTRADIOL + NORETHISTERONE
Pack containing 21 tablets 1 mg-35 micrograms and 7 inert tablets 67,860 67,860
ETHINYLOESTRADIOL + NORETHISTERONE
Pack containing 21 tablets 500 micrograms-35 micrograms and 7 inert tablets
84,478 84,478
ETHOSUXIMIDE Capsule 250 mg 3 3
ETHOSUXIMIDE Oral solution 250 mg per 5 mL, 200 mL 1,088 1,088
EXEMESTANE Tablet 25 mg 1 1 EXTEMPORANEOUSLY PREPARED Creams 34,889 21 34,910
EXTEMPORANEOUSLY PREPARED Dusting powder 22 22
EXTEMPORANEOUSLY PREPARED Ear drops 698 698
EXTEMPORANEOUSLY PREPARED Eye drops, other 100 2 102
EXTEMPORANEOUSLY PREPARED Eye lotions 12 12
EXTEMPORANEOUSLY PREPARED Inhalations 24 24
EXTEMPORANEOUSLY PREPARED Linctuses containing codeine 828 828
EXTEMPORANEOUSLY PREPARED Linctuses, other 270 1 271
EXTEMPORANEOUSLY PREPARED Lotions 2,371 2,371
EXTEMPORANEOUSLY PREPARED
Mixtures for children containing codeine 8 8
EXTEMPORANEOUSLY PREPARED Mixtures for children, other 735 735
EXTEMPORANEOUSLY PREPARED Mixtures, other 1,115 1,115
EXTEMPORANEOUSLY PREPARED Mouth washes 249 249
EXTEMPORANEOUSLY PREPARED Nasal instillations 41 1 42
24 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
EXTEMPORANEOUSLY PREPARED Ointments, waxes 4,709 2 4,711
EXTEMPORANEOUSLY PREPARED Paints 63 63
EXTEMPORANEOUSLY PREPARED Pastes containing cocaine hcl 26 26
EXTEMPORANEOUSLY PREPARED Pastes, other 1,275 1,275
EXTEMPORANEOUSLY PREPARED Powders for internal use 156 156
EXTEMPORANEOUSLY PREPARED Solutions 971 7 978
EZETIMIBE Tablet 10 mg 28 28 EZETIMIBE + SIMVASTATIN Tablet 10 mg-20 mg 2 2 EZETIMIBE + SIMVASTATIN Tablet 10 mg-40 mg 9 9 EZETIMIBE + SIMVASTATIN Tablet 10 mg-80 mg 11 11 FAMCICLOVIR Tablet 125 mg 1 1 FAMCICLOVIR Tablet 250 mg 3 3 FAMCICLOVIR Tablet 500 mg 2 2 FAMOTIDINE Tablet 20 mg 5,173 2 5,175 FAMOTIDINE Tablet 40 mg 8,565 8,565 FELODIPINE Tablet 10 mg (extended release) 88,962 4 88,966 FELODIPINE Tablet 2.5 mg (extended release) 26,072 7 26,079 FELODIPINE Tablet 5 mg (extended release) 69,870 1 69,871 FENOFIBRATE Tablet 145 mg 248 248 FENOFIBRATE Tablet 48 mg 14,116 1 14,117 FENTANYL Transdermal patch 1.28 mg 181 181 FENTANYL Transdermal patch 12.6 mg 4 4 FENTANYL Transdermal patch 2.063 mg 157 157 FENTANYL Transdermal patch 2.1 mg 1,861 1,861 FENTANYL Transdermal patch 2.55 mg 12 12 FENTANYL Transdermal patch 4.125 mg 10 10 FENTANYL Transdermal patch 4.2 mg 182 182 FENTANYL Transdermal patch 5.10 mg 3 3 FENTANYL Transdermal patch 8.25 mg 1 1 FENTANYL Transdermal patch 8.4 mg 40 40
FERROUS FUMARATE Tablet 200 mg (equivalent to 65.7 mg iron) 2,183 5 2,188
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 25
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
FERROUS FUMARATE + FOLIC ACID
Tablet 310 mg (equivalent to 100 mg iron)-350 micrograms 10,538 60 10,598
FERROUS SULFATE Oral liquid 30 mg per mL, 250 mL 5,774 5,774
FLECAINIDE Tablet containing flecainide acetate 100 mg 162 162
FLECAINIDE Tablet containing flecainide acetate 50 mg 609 609
FLUCLOXACILLIN Capsule 250 mg (as sodium) 27,770 11 27,781 FLUCLOXACILLIN Capsule 500 mg (as sodium) 229,499 14 229,513
FLUCLOXACILLIN Powder for injection 1 g (as sodium) 4,690 4,690
FLUCLOXACILLIN Powder for injection 500 mg (as sodium) 112 112
FLUCLOXACILLIN Powder for oral liquid 125 mg (as sodium) per 5 mL, 100 mL 12,409 12,409
FLUCLOXACILLIN Powder for oral liquid 250 mg (as sodium) per 5 mL, 100 mL 26,868 26,868
FLUCONAZOLE Capsule 100 mg 42 42 FLUCONAZOLE Capsule 200 mg 51 1 52 FLUCONAZOLE Capsule 50 mg 113 1 114
FLUCONAZOLE Solution for I.V. infusion 100 mg in 50 mL 1 1
FLUCONAZOLE Solution for I.V. infusion 200 mg in 100 mL 5 5
FLUDROCORTISONE ACETATE
Tablet containing fludrocortisone acetate 100 micrograms 956 5 961
FLUOROMETHOLONE Eye drops 1 mg per mL, 5 mL 102,671 3 102,674
FLUOROMETHOLONE ACETATE
Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL
30,853 7 30,860
FLUOXETINE Capsule 20 mg (as hydrochloride) 447,498 3 447,501
FLUOXETINE Tablet, dispersible, 20 mg (as hydrochloride) 145,266 145,266
FLUPENTHIXOL DECANOATE
Oily I.M. injection 100 mg in 1 mL ampoule 5 5
FLUPENTHIXOL DECANOATE Oily I.M. injection 20 mg in 1 mL 376 376
FLUPHENAZINE DECANOATE
Injection 12.5 mg in 0.5 mL ampoule 99 99
26 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
FLUPHENAZINE DECANOATE Injection 25 mg in 1 mL ampoule 205 205
FLUPHENAZINE DECANOATE Injection 50 mg in 2 mL ampoule 14 14
FLURBIPROFEN Eye drops containing flurbiprofen sodium 300 micrograms per mL, single dose units 0.4 mL, 5
225 225
FLUTICASONE
Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses
6,728 6,728
FLUTICASONE
Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses
16,704 16,704
FLUTICASONE
Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation)
55,027 55,027
FLUTICASONE
Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation)
2 2
FLUTICASONE
Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation)
111,361 111,361
FLUVASTATIN Capsule 20 mg (as sodium) 3,674 3,674 FLUVASTATIN Capsule 40 mg (as sodium) 4,597 4,597
FLUVOXAMINE Tablet containing fluvoxamine maleate 100 mg 83,681 83,681
FLUVOXAMINE Tablet containing fluvoxamine maleate 50 mg 52,350 2 52,352
FOLIC ACID Tablet 5 mg 14,301 49 14,350 FOLIC ACID Tablet 500 micrograms 4,480 12 4,492
FOLINIC ACID Injection containing calcium folinate equivalent to 100 mg folinic acid in 10 mL
230 230
FOLINIC ACID Injection containing calcium folinate equivalent to 300 mg folinic acid in 30 mL
9 9
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 27
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
FOLINIC ACID Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL
3,126 3,126
FOLINIC ACID Tablet containing calcium folinate equivalent to 15 mg folinic acid 115 115
FOSINOPRIL Tablet containing fosinopril sodium 10 mg 22,488 22,488
FOSINOPRIL Tablet containing fosinopril sodium 20 mg 41,463 2 41,465
FOSINOPRIL + HYDROCHLOROTHIAZIDE
Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg
11,947 11,947
FOSINOPRIL + HYDROCHLOROTHIAZIDE
Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg
80,379 80,379
FRAMYCETIN SULFATE Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL
29,692 29,692
FRUSEMIDE Injection 20 mg in 2 mL 1,129 1,129 FRUSEMIDE Oral solution 10 mg per mL, 30 mL 1,037 1,037 FRUSEMIDE Tablet 20 mg 35,129 214 35,343 FRUSEMIDE Tablet 40 mg 112,567 744 113,311 FRUSEMIDE Tablet 500 mg 1,300 1,300
FUSIDATE Tablet containing sodium fusidate 250 mg 13 13
GABAPENTIN Capsule 100 mg 2,006 2,006 GABAPENTIN Capsule 300 mg 97 97 GABAPENTIN Capsule 400 mg 2 2
GALANTAMINE Capsule (prolonged release) 16 mg (as hydrobromide) 1 1
GELATIN-SUCCINYLATED I.V. infusion 20 g per 500 mL, 500 mL 252 252
GEMFIBROZIL Tablet 600 mg 38,474 2 38,476
GENTAMICIN Eye drops 3 mg (as sulfate) per mL, 5 mL 3,601 3,601
GENTAMICIN Injection 80 mg (as sulfate) in 2 mL 6,366 6,366 GENTIAN ALKALINE Mixture pl 200mL 9 9 GLIBENCLAMIDE Tablet 5 mg 12,972 6 12,978 GLICLAZIDE Tablet 30 mg (modified release) 48,589 13 48,602 GLICLAZIDE Tablet 60 mg (modified release) 319,394 11 319,405
28 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
GLICLAZIDE Tablet 80 mg 34,809 2 34,811 GLIMEPIRIDE Tablet 1 mg 9,157 8 9,165 GLIMEPIRIDE Tablet 2 mg 15,174 10 15,184 GLIMEPIRIDE Tablet 3 mg 5,335 5,335 GLIMEPIRIDE Tablet 4 mg 39,988 1 39,989 GLIPIZIDE Tablet 5 mg 7,925 5 7,930
GLUCAGON HYDROCHLORIDE
Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe
114 114
GLUCOSE I.V. infusion 139 mmol (anhydrous) per 500 mL, 500 mL 66 66
GLUCOSE I.V. infusion 278 mmol (anhydrous) per 500 mL, 500 mL 1 1
GLUCOSE I.V. infusion 278 mmol (anhydrous) per L, 1 L 27 27
GLUCOSE I.V. infusion 69.5 mmol (anhydrous) per 250 mL, 250 mL 70 70
GLUCOSE and KETONE INDICATOR URINE
Test strips, 50 (Keto-Diabur-Test 5000) 1 1
GLUCOSE and KETONE INDICATOR URINE Test strips, 50 (Keto-Diastix) 50 50
GLUCOSE INDICATOR BLOOD Test strips, 50 (Accu-Chek Go) 45 45
GLUCOSE INDICATOR BLOOD Test strips, 50 (AgaMatrix Jazz) 1 1
GLUCOSE INDICATOR BLOOD Test strips, 50 (CareSens N) 2 2
GLUCOSE INDICATOR BLOOD Test strips, 50 (CareSens) 4 4
GLUCOSE INDICATOR BLOOD Test strips, 50 (GlucoDr) 2 2
GLUCOSE INDICATOR BLOOD Test strips, 50 (Lifeline Attest) 1 1
GLUCOSE INDICATOR BLOOD Test strips, 50 (OneTouch Verio) 16 16
GLUCOSE INDICATOR BLOOD Test strips, 50 (Optium Omega) 11 11
GLUCOSE INDICATOR BLOOD Test strips, 50 (TRUEbalance) 6 6
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 29
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
GLUCOSE INDICATOR BLOOD Test strips, 50 (TRUEresult) 19 19
GLUCOSE INDICATOR BLOOD Test strips, 50 (TrueTrack) 7 7
GLUCOSE INDICATOR BLOOD Test strips, 51 (Accu-Chek Integra) 12 12
GLUCOSE INDICATOR URINE Test strips, 50 (Diastix) 6 6
GLYCEROL Suppositories 1.4 g, 12 72 72 GLYCEROL Suppositories 2.8 g, 12 484 5 489 GLYCEROL Suppositories 700 mg, 12 100 100
GLYCERYL TRINITRATE Sublingual spray (pump pack) 400 micrograms per dose, 200 doses 31,649 31,649
GLYCERYL TRINITRATE Tablets 600 micrograms, 100 4,870 4,870 GLYCERYL TRINITRATE Transdermal patch 120 mg 560 1 561 GLYCERYL TRINITRATE Transdermal patch 18 mg 324 324 GLYCERYL TRINITRATE Transdermal patch 25 mg 7,813 2 7,815 GLYCERYL TRINITRATE Transdermal patch 36 mg 182 182 GLYCERYL TRINITRATE Transdermal patch 40 mg 6,352 6,352 GLYCERYL TRINITRATE Transdermal patch 50 mg 2,596 2 2,598 GLYCERYL TRINITRATE Transdermal patch 54 mg 84 84 GLYCERYL TRINITRATE Transdermal patch 80 mg 1,639 1,639
GRANISETRON Concentrated injection 3 mg (as hydrochloride) in 3 mL 10,756 10,756
GRANISETRON Tablet 2 mg (as hydrochloride) 651 651 GRISEOFULVIN Tablet 125 mg 1,807 1,807 GRISEOFULVIN Tablet 500 mg 24,406 24,406 HALOPERIDOL Injection 5 mg in 1 mL 1,115 1 1,116 HALOPERIDOL Oral solution 2 mg per mL, 100 mL 84 84 HALOPERIDOL Tablet 1.5 mg 1,636 1 1,637 HALOPERIDOL Tablet 5 mg 1,374 3 1,377 HALOPERIDOL Tablet 500 micrograms 4,663 39 4,702
HALOPERIDOL DECANOATE I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule 6 6
HALOPERIDOL DECANOATE I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule 129 129
HEPARIN SODIUM Injection (preservative-free) 5,000 I.U. (as sodium) in 5 mL 80 80
30 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
HEPARIN SODIUM Injection 35,000 units (as sodium) in 35 mL 10 10
HEPARIN SODIUM Injection 5,000 units (as sodium) in 0.2 mL 15,386 15,386
HEXAMINE HIPPURATE Tablet containing hexamine hippurate 1 g 100 3 103
HOMATROPINE Eye drops containing homatropine hydrobromide 20 mg per mL, 15mL 7,409 7,409
HYDRALAZINE Tablet containing hydralazine hydrochloride 25 mg 5,191 4 5,195
HYDRALAZINE Tablet containing hydralazine hydrochloride 50 mg 4,946 1 4,947
HYDROCHLOROTHIAZIDE Tablet 25 mg 24,980 12 24,992
HYDROCHLOROTHIAZIDE + AMILORIDE
Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg
35,772 4 35,776
HYDROCHLOROTHIAZIDE + TRIAMTERENE Tablet 25 mg-50 mg 5,124 1 5,125
HYDROCORTISONE Tablet 20 mg 9,465 9,465 HYDROCORTISONE Tablet 4 mg 7,568 7,568
HYDROCORTISONE ACETATE
Cream containing hydrocortisone acetate 10 mg per g, 30 g 44,746 15 44,761
HYDROCORTISONE ACETATE
Cream containing hydrocortisone acetate 10 mg per g, 50 g 64,963 16 64,979
HYDROCORTISONE ACETATE
Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g
27,677 5 27,682
HYDROCORTISONE ACETATE
Ointment containing hydrocortisone acetate 10 mg per g, 30 g
15,208 4 15,212
HYDROCORTISONE ACETATE
Ointment containing hydrocortisone acetate 10 mg per g, 50 g
27,596 5 27,601
HYDROCORTISONE ACETATE
Rectal foam containing hydrocortisone acetate 90 mg per applicatorful, 14 applications, aerosol 21.1 g
469 469
HYDROCORTISONE SODIUM SUCCINATE
Injection 100 mg (as sodium succinate) with 2 mL solvent 2,544 2,544
HYDROCORTISONE SODIUM SUCCINATE
Injection 250 mg (as sodium succinate) with 2 mL solvent 207 207
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 31
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
HYDROMORPHONE Injection containing hydromorphone hydrochloride 10 mg in 1 mL
592 592
HYDROMORPHONE Injection containing hydromorphone hydrochloride 2 mg in 1 mL
755 755
HYDROMORPHONE Injection containing hydromorphone hydrochloride 50 mg in 5 mL
20 20
HYDROMORPHONE Tablet (modified release) containing hydromorphone hydrochloride 16 mg
13 13
HYDROMORPHONE Tablet (modified release) containing hydromorphone hydrochloride 32 mg
4 4
HYDROMORPHONE Tablet (modified release) containing hydromorphone hydrochloride 4 mg
2,287 2,287
HYDROMORPHONE Tablet (modified release) containing hydromorphone hydrochloride 8 mg
231 231
HYDROMORPHONE Tablet containing hydromorphone hydrochloride 2 mg 1,067 1,067
HYDROMORPHONE Tablet containing hydromorphone hydrochloride 4 mg 625 625
HYDROMORPHONE Tablet containing hydromorphone hydrochloride 8 mg 410 410
HYDROXOCOBALAMIN Injection 1 mg (as acetate) in 1 mL 4,056 4,056 HYDROXOCOBALAMIN Injection 1 mg (as chloride) in 1 mL 55,925 5 55,930
HYDROXYCHLOROQUINE Tablet containing hydroxychloroquine sulfate 200 mg
72,261 72,261
HYDROXYUREA Capsule 500 mg 28 28
HYOSCINE BUTYLBROMIDE Injection containing hyoscine butylbromide 20 mg in 1 mL 23 23
HYPROMELLOSE Eye drops 3 mg per mL, 15 mL 4,552 16 4,568 HYPROMELLOSE Eye drops 5 mg per mL, 15 mL 482 7 489 HYPROMELLOSE Oral gel 20 mg per g, 100 g 4 4 IBUPROFEN Tablet 400 mg 208,967 48 209,015
IMIPRAMINE Tablet containing imipramine hydrochloride 10 mg 6,847 2 6,849
32 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
IMIPRAMINE Tablet containing imipramine hydrochloride 25 mg 19,153 4 19,157
INDACATEROL Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler)
2 2
INDAPAMIDE Tablet containing indapamide hemihydrate 1.5 mg (sustained release)
75,317 1 75,318
INDAPAMIDE Tablet containing indapamide hemihydrate 2.5 mg 27,029 27,029
INDOMETHACIN Capsule 25 mg 173,533 7 173,540 INDOMETHACIN Suppository 100 mg 20,668 20,668
INSULIN ASPART Injection (human analogue) 100 units per mL, 10 mL vial 12 12
INSULIN GLULISINE Injection (human analogue) 100 units per mL, 10 mL 3 3
INSULIN ISOPHANE HUMAN
Injection (human) 100 units per mL, 10 mL 39 39
INSULIN ISOPHANE HUMAN + INSULIN NEUTRAL HUMAN
Injection (human) 30 units-70 units per mL, 10 mL 18 18
INSULIN LISPRO Injection (human analogue) 100 units per mL, 10 mL vial 2 2
INSULIN NEUTRAL HUMAN Injection (human) 100 units per mL, 10 mL 129 129
IPRATROPIUM
Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30
1,555 1,555
IPRATROPIUM
Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30
2,629 2,629
IPRATROPIUM
Pressurised inhalation containing ipratropium bromide 21 micrograms per dose, 200 doses (CFC-free formulation)
13,183 13,183
IRBESARTAN Tablet 150 mg 535,858 10 535,868 IRBESARTAN Tablet 300 mg 530,055 12 530,067 IRBESARTAN Tablet 75 mg 167,170 14 167,184
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 33
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
IRBESARTAN + HYDROCHLOROTHIAZIDE Tablet 150 mg-12.5 mg 196,567 1 196,568
IRBESARTAN + HYDROCHLOROTHIAZIDE Tablet 300 mg-12.5 mg 576,938 576,938
IRBESARTAN + HYDROCHLOROTHIAZIDE Tablet 300 mg-25 mg 186,481 186,481
IRON POLYMALTOSE Injection 100 mg (iron) in 2 mL ampoule 750 750
ISONIAZID Tablet 100 mg 1,559 1,559 ISOSORBIDE DINITRATE Tablet 5 mg (sublingual) 389 1 390
ISOSORBIDE MONONITRATE Tablet 120 mg (sustained release) 11,362 5 11,367
ISOSORBIDE MONONITRATE Tablet 60 mg (sustained release) 48,622 137 48,759
ISOTRETINOIN Capsule 20 mg 5 5 IVERMECTIN Tablet 3 mg 780 780 KAOLIN Mixture bpc 200mL 44 44 KETOCONAZOLE Cream 20 mg per g, 30 g 387 387 KETOCONAZOLE Shampoo 10 mg per g, 100 mL 19 19 KETOCONAZOLE Shampoo 20 mg per g, 60 mL 43 43 KETOCONAZOLE Tablet 200 mg 13,385 13,385 KETOPROFEN Capsule 200 mg (sustained release) 37,225 1 37,226 KETOPROFEN Suppository 100 mg 265 265
LABETALOL Tablet containing labetalol hydrochloride 100 mg 9,984 9,984
LABETALOL Tablet containing labetalol hydrochloride 200 mg 8,723 8,723
LACOSAMIDE Tablet 100 mg 1 1 LACOSAMIDE Tablet 50 mg 68 68
LACTATE + SODIUM CHLORIDE + POTASSIUM CHLORIDE + CALCIUM CHLORIDE DIHYDRATE
I.V. infusion containing approximately 131 mmol sodium (as lactate and chloride), 5 mmol potassium (as chloride), 2 mmol calcium (as chloride), 29 mmol bicarbonate (as lactate) and 111 mmol chloride per L, 1 L
1,312 1,312
34 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
LACTATE + SODIUM CHLORIDE + POTASSIUM CHLORIDE + CALCIUM CHLORIDE DIHYDRATE
I.V. infusion containing approximately 65 mmol sodium (as lactate and chloride), 2.7 mmol potassium (as chloride), 0.9 mmol calcium (as chloride), 14 mmol bicarbonate (as lactate) and 56 mmol chloride per 500 mL, 500 mL
33 33
LACTULOSE Solution BP 3.34g per 5 mL, 500 mL 29,355 209 29,564 LAMOTRIGINE Tablet 100 mg 14 14 LAMOTRIGINE Tablet 200 mg 4 4 LAMOTRIGINE Tablet 25 mg 8,491 8,491 LAMOTRIGINE Tablet 5 mg 634 634 LAMOTRIGINE Tablet 50 mg 18,381 18,381 LANSOPRAZOLE Capsule 15 mg 1,627 1,627 LANSOPRAZOLE Capsule 30 mg 49,056 49,056 LANSOPRAZOLE Tablet 15 mg (orally disintegrating) 8,489 8,489 LANSOPRAZOLE Tablet 30 mg (orally disintegrating) 91,070 2 91,072
LATANOPROST Eye drops 50 micrograms per mL, 2.5 mL 1,534 1,534
LATANOPROST + TIMOLOL Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL
151 151
LEFLUNOMIDE Tablet 10 mg 1 1 LEFLUNOMIDE Tablet 20 mg 2 2
LERCANIDIPINE Tablet containing lercanidipine hydrochloride 10 mg 245,107 80 245,187
LERCANIDIPINE Tablet containing lercanidipine hydrochloride 20 mg 255,544 7 255,551
LERCANIDIPINE + ENALAPRIL
Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg
16,145 16,145
LERCANIDIPINE + ENALAPRIL
Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg
35,919 35,919
LETROZOLE Tablet 2.5 mg 4 4 LEVETIRACETAM Tablet 1 g 4 4 LEVETIRACETAM Tablet 250 mg 45 45 LEVETIRACETAM Tablet 500 mg 56 56
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 35
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
LEVODOPA + BENSERAZIDE Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride)
20 1 21
LEVODOPA + BENSERAZIDE Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) (sustained release)
22 3 25
LEVODOPA + BENSERAZIDE Capsule containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride)
2,149 1 2,150
LEVODOPA + BENSERAZIDE Dispersible tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride)
5 5
LEVODOPA + BENSERAZIDE Dispersible tablet containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride)
829 1 830
LEVODOPA + BENSERAZIDE Tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride)
174 2 176
LEVODOPA + BENSERAZIDE Tablet containing levodopa 200 mg with 50 mg benserazide (as hydrochloride)
10 1 11
LEVODOPA + CARBIDOPA ANHYDROUS Tablet 100 mg-25 mg (anhydrous) 297 6 303
LEVODOPA + CARBIDOPA ANHYDROUS
Tablet 200 mg-50 mg (anhydrous) (modified release) 22 22
LEVODOPA + CARBIDOPA ANHYDROUS Tablet 250 mg-25 mg (anhydrous) 17 17
LEVONORGESTREL Tablets 30 micrograms, 28 97,399 97,399
LEVONORGESTREL + ETHINYLOESTRADIOL
Pack containing 21 tablets 100 micrograms-20 micrograms and 7 inert tablets
29 29
LEVONORGESTREL + ETHINYLOESTRADIOL
Pack containing 21 tablets 125 micrograms-50 micrograms and 7 inert tablets
55,127 55,127
LEVONORGESTREL + ETHINYLOESTRADIOL
Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets
1,204,948 1,204,948
LEVONORGESTREL + ETHINYLOESTRADIOL
Pack containing 6 tablets 50 micrograms-30 micrograms, 5 tablets 75 micrograms-40 micrograms, 10 tablets 125 micrograms-30 micrograms and 7 inert tablets
238,584 238,584
36 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
LIGNOCAINE Infusion containing lignocaine hydrochloride 500 mg in 5 mL 83 83
LIGNOCAINE Injection containing lignocaine hydrochloride 100 mg in 5 mL 17 17
LINAGLIPTIN Tablet 5 mg 5 5
LINCOMYCIN Injection 600 mg (as hydrochloride) in 2 mL 977 977
LIOTHYRONINE Tablet containing liothyronine sodium 20 micrograms 29 29
LISINOPRIL Tablet 10 mg 43,014 1 43,015 LISINOPRIL Tablet 20 mg 71,107 1 71,108 LISINOPRIL Tablet 5 mg 21,481 7 21,488
LITHIUM CARBONATE Tablet containing lithium carbonate 250 mg 34,720 3 34,723
LITHIUM CARBONATE Tablet containing lithium carbonate 450 mg (slow release) 18,741 18,741
LOPERAMIDE Capsule containing loperamide hydrochloride 2 mg 34,554 38 34,592
LORATADINE Tablet 10 mg 7 7
LOSARTAN Tablet containing losartan potassium 25 mg 1,007 1,007
LOSARTAN Tablet containing losartan potassium 50 mg 2,617 2,617
MACROGOL-3350 Powder for oral solution 510 g 5,240 5,240
MACROGOL-3350 Sachets containing powder for oral solution 17 g, 30 86 86
MACROGOL-3350 + SODIUM CHLORIDE + POTASSIUM CHLORIDE + BICARBONATE
Sachets containing powder for oral solution 13.125 g with electrolytes, 30
44,806 44,806
MAGNESIUM ASPARTATE DIHYDRATE
Tablet 37.4 mg (as aspartate dihydrate) 53 42 95
MEBEVERINE Tablet 135 mg 1 1
MEDROXYPROGESTERONE Injection containing medroxyprogesterone acetate 150 mg in 1 mL
128,483 128,483
MEDROXYPROGESTERONE Tablet containing medroxy-progesterone acetate 10 mg 27,688 27,688
MEDROXYPROGESTERONE Tablet containing medroxy-progesterone acetate 100 mg 3 3
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 37
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
MEDROXYPROGESTERONE Tablet containing medroxy-progesterone acetate 200 mg 1 1
MEDROXYPROGESTERONE Tablet containing medroxy-progesterone acetate 5 mg 30,849 30,849
MEFENAMIC ACID Capsule 250 mg 26,812 26,812 MELOXICAM Capsule 15 mg 271,182 271,182 MELOXICAM Capsule 7.5 mg 96,328 96,328 MELOXICAM Tablet 15 mg 311,540 311,540 MELOXICAM Tablet 7.5 mg 86,679 3 86,682 MELPHALAN Tablet 2 mg 15 15
MENTHOL with EUCALYPTUS Menthol/eucalypt inh 50mL 161 161
MERCAPTOPURINE Tablet 50 mg 11 11
MESALAZINE Sachet containing granules, 1 g per sachet 1 1
MESALAZINE Suppository (moulded) 1 g 1 1 MESALAZINE Suppository 1 g 1 1 MESALAZINE Tablet 1 g (prolonged release) 1 1 MESALAZINE Tablet 250 mg (enteric coated) 2 2
MESNA Solution for I.V. injection 1 g in 10 mL ampoule 43 43
MESNA Solution for I.V. injection 400 mg in 4 mL ampoule 295 295
MESTRANOL + NORETHISTERONE
Pack containing 21 tablets 1 mg-50 micrograms and 7 inert tablets 10,068 10,068
METFORMIN Tablet (extended release) containing metformin hydrochloride 1 g
200,856 1 200,857
METFORMIN Tablet (extended release) containing metformin hydrochloride 500 mg
460,543 9 460,552
METFORMIN Tablet containing metformin hydrochloride 1 g 309,570 7 309,577
METFORMIN Tablet containing metformin hydrochloride 500 mg 300,057 62 300,119
METFORMIN Tablet containing metformin hydrochloride 850 mg 65,159 10 65,169
METFORMIN + GLIBENCLAMIDE
Tablet containing metformin hydrochloride 250 mg with glibenclamide 1.25 mg
487 487
38 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
METFORMIN + GLIBENCLAMIDE
Tablet containing metformin hydrochloride 500 mg with glibenclamide 2.5 mg
8,174 8,174
METFORMIN + GLIBENCLAMIDE
Tablet containing metformin hydrochloride 500 mg with glibenclamide 5 mg
19,427 19,427
METHADONE Injection containing methadone hydrochloride 10 mg in 1 mL 12 12
METHADONE Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 200 mL
41 41
METHADONE Tablet containing methadone hydrochloride 10 mg 8,293 5 8,298
METHOTREXATE Injection 5 mg in 2 mL vial 91 91 METHOTREXATE Injection 50 mg in 2 mL vial 5,695 5,695 METHOTREXATE Tablet 10 mg 23,380 2 23,382 METHOTREXATE Tablet 2.5 mg 18,792 1 18,793 METHYLDOPA Tablet 250 mg 36,136 4 36,140
METHYLPHENIDATE Capsule containing methylphenidate hydrochloride 10 mg (modified release)
3,503 3,503
METHYLPHENIDATE Capsule containing methylphenidate hydrochloride 20 mg (modified release)
20 20
METHYLPHENIDATE Capsule containing methylphenidate hydrochloride 40 mg (modified release)
1 1
METHYLPHENIDATE Tablet containing methylphenidate hydrochloride 10 mg 47,234 47,234
METHYLPHENIDATE Tablet containing methylphenidate hydrochloride 18 mg (extended release)
1 1
METHYLPHENIDATE Tablet containing methylphenidate hydrochloride 27 mg (extended release)
1 1
METHYLPHENIDATE Tablet containing methylphenidate hydrochloride 54 mg (extended release)
1 1
METHYLPREDNISOLONE Cream containing methylprednisolone aceponate 1 mg per g, 15 g
86,314 86,314
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 39
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
METHYLPREDNISOLONE Fatty ointment containing methylprednisolone aceponate 1 mg per g, 15 g
97,723 97,723
METHYLPREDNISOLONE Injection containing methylprednisolone acetate 40 mg in 1 mL
15,675 15,675
METHYLPREDNISOLONE Lotion containing methylprednisolone aceponate 1 mg per g, 20 g
4,960 4,960
METHYLPREDNISOLONE Ointment containing methylprednisolone aceponate 1 mg per g, 15 g
50,832 50,832
METHYLPREDNISOLONE Powder for injection 40 mg (as sodium succinate) 272 272
METHYLPREDNISOLONE Powder for injection 40 mg (as sodium succinate) with diluent 682 682
METHYSERGIDE Tablet 1 mg (as maleate) 82 82
METOCLOPRAMIDE Injection containing metoclopramide hydrochloride 10 mg in 2 mL
5,652 2 5,654
METOCLOPRAMIDE Tablet containing metoclopramide hydrochloride 10 mg 376,111 446 376,557
METOPROLOL SUCCINATE Tablet 190 mg (controlled release) 1 1
METOPROLOL SUCCINATE Tablet 23.75 mg (controlled release) 706 706
METOPROLOL SUCCINATE Tablet 47.5 mg (controlled release) 3 3 METOPROLOL SUCCINATE Tablet 95 mg (controlled release) 2 2
METOPROLOL TARTRATE Tablet containing metoprolol tartrate 100 mg 85,953 39 85,992
METOPROLOL TARTRATE Tablet containing metoprolol tartrate 50 mg 328,926 675 329,601
METRONIDAZOLE I.V. infusion 500 mg in 100 mL 6,277 6,277
METRONIDAZOLE Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL
15,972 15,972
METRONIDAZOLE Suppositories 500 mg, 10 389 389 METRONIDAZOLE Tablet 200 mg 86,380 16 86,396 METRONIDAZOLE Tablet 400 mg 296,873 140 297,013
MIANSERIN Tablet containing mianserin hydrochloride 10 mg 3,250 3,250
40 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
MIANSERIN Tablet containing mianserin hydrochloride 20 mg 3,928 1 3,929
MICONAZOLE Cream containing miconazole nitrate 20 mg per g, 15 g 26 26
MICONAZOLE Cream containing miconazole nitrate 20 mg per g, 30 g 99 99
MICONAZOLE Cream containing miconazole nitrate 20 mg per g, 70 g 47 47
MICONAZOLE Lotion containing miconazole nitrate 20 mg per mL, 30 g 14 14
MICONAZOLE Powder containing miconazole nitrate 20 mg per g, 30 g 16 16
MICONAZOLE Tincture 20 mg per mL, 30 mL 10 10
MILK POWDER LACTOSE FREE FORMULA Oral powder 900 g (S-26 LF) 3 3
MINOCYCLINE Tablet 50 mg (as hydrochloride) 208,705 2 208,707 MINOXIDIL Tablet 10 mg 1 1 MIRTAZAPINE Tablet 15 mg 32,451 2 32,453 MIRTAZAPINE Tablet 15 mg (orally disintegrating) 29,735 3 29,738 MIRTAZAPINE Tablet 30 mg 201,110 19 201,129 MIRTAZAPINE Tablet 30 mg (orally disintegrating) 19,020 19,020 MIRTAZAPINE Tablet 45 mg 56,165 4 56,169 MIRTAZAPINE Tablet 45 mg (orally disintegrating) 1,123 1,123 MISOPROSTOL Tablet 200 micrograms 12 12 MOCLOBEMIDE Tablet 150 mg 12,877 1 12,878 MOCLOBEMIDE Tablet 300 mg 22,663 1 22,664
MOMETASONE Cream containing mometasone furoate 1 mg per g, 15 g 185,518 3 185,521
MOMETASONE Lotion containing mometasone furoate 1 mg per g, 30 mL 99,316 99,316
MOMETASONE Ointment containing mometasone furoate 1 mg per g, 15 g 99,627 1 99,628
MONTELUKAST Tablet, chewable, 4 mg (as sodium) 12 12 MONTELUKAST Tablet, chewable, 5 mg (as sodium) 26 26
MORPHINE Capsule containing morphine sulfate 10 mg (containing sustained release pellets)
1,977 1,977
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 41
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
MORPHINE Capsule containing morphine sulfate 100 mg (containing sustained release pellets)
15 15
MORPHINE Capsule containing morphine sulfate 20 mg (containing sustained release pellets)
2,113 2,113
MORPHINE Capsule containing morphine sulfate 30 mg (controlled release) 123 123
MORPHINE Capsule containing morphine sulfate 50 mg (containing sustained release pellets)
315 315
MORPHINE Capsule containing morphine sulfate 60 mg (controlled release) 6 6
MORPHINE Capsule containing morphine sulfate 90 mg (controlled release) 8 8
MORPHINE Injection containing morphine sulfate 10 mg in 1 mL 5,312 49 5,361
MORPHINE Injection containing morphine sulfate 15 mg in 1 mL 1,201 2 1,203
MORPHINE Injection containing morphine sulfate 30 mg in 1 mL 2,060 2,060
MORPHINE Injection containing morphine sulphate 10 mg in 1 mL (with preservative)
283 3 286
MORPHINE Injection containing morphine tartrate 120 mg in 1.5 mL 278 278
MORPHINE Oral solution containing morphine hydrochloride 10 mg per mL, 200 mL
2,684 2,684
MORPHINE Oral solution containing morphine hydrochloride 2mg per mL, 200 mL 1,924 1,924
MORPHINE Oral solution containing morphine hydrochloride 5mg per mL, 200 mL 3,077 3,077
MORPHINE
Sachet containing controlled release granules for oral suspension, containing morphine sulfate 20 mg per sachet
47 47
MORPHINE
Sachet containing controlled release granules for oral suspension, containing morphine sulfate 30 mg per sachet
6 6
42 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
MORPHINE
Sachet containing controlled release granules for oral suspension, containing morphine sulfate 60 mg per sachet
1 1
MORPHINE Tablet containing morphine sulfate 10 mg 438 1 439
MORPHINE Tablet containing morphine sulfate 10 mg (controlled release) 6,862 1 6,863
MORPHINE Tablet containing morphine sulfate 100 mg (controlled release) 18 18
MORPHINE Tablet containing morphine sulfate 15 mg (controlled release) 2,853 2,853
MORPHINE Tablet containing morphine sulfate 20 mg 197 197
MORPHINE Tablet containing morphine sulfate 30 mg 1,321 1,321
MORPHINE Tablet containing morphine sulfate 30 mg (controlled release) 2,047 2,047
MORPHINE Tablet containing morphine sulfate 5 mg (controlled release) 2,777 2 2,779
MORPHINE Tablet containing morphine sulfate 60 mg (controlled release) 42 42
MOXONIDINE Tablet 200 micrograms 75,344 75,344 MOXONIDINE Tablet 400 micrograms 79,189 79,189
MUPIROCIN Nasal ointment 20 mg (as calcium) per g, 3 g 2,262 2,262
MYCOPHENOLATE Capsule containing mycophenolate mofetil 250 mg 1 1
MYCOPHENOLATE Tablet containing mycophenolate mofetil 500 mg 2 2
NALOXONE Injection containing naloxone hydrochloride 400 micrograms in 1 mL pre-filled syringe
2 2
NALTREXONE Tablet containing naltrexone hydrochloride 50 mg 9 9
NANDROLONE DECANOATE
Injection 50 mg in 1 mL disposable syringe 15 15
NAPROXEN Tablet 1 g (sustained release) 115,927 115,927 NAPROXEN Tablet 250 mg 26,358 3 26,361 NAPROXEN Tablet 500 mg 92,622 92,622 NAPROXEN Tablet 750 mg (sustained release) 56,355 56,355
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 43
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
NAPROXEN Tablet containing naproxen sodium 550 mg 18,726 18,726
NARATRIPTAN Tablet 2.5 mg (as hydrochloride) 27,999 27,999 NEBIVOLOL Tablet 1.25 mg (as hydrochloride) 631 631
NEBIVOLOL Tablet 1.25 mg (as hydrochloride), 28 281 281
NEDOCROMIL Pressurised inhalation containing nedocromil sodium 2 mg per dose, 112 doses (CFC-free formulation)
100 100
NEOMYCIN + BACITRACIN ZINC
Ear ointment 3.5 mg neomycin (as undecenoate) with bacitracin zinc 400 units per g, 10 g
9 9
NICORANDIL Tablets 10 mg, 60 10,509 10,509 NICORANDIL Tablets 20 mg, 60 3,733 3,733 NICOTINE Transdermal patch 114 mg 12 1 13 NICOTINE Transdermal patch 17.5 mg 1 1 NICOTINE Transdermal patch 24.9 mg 1 1 NICOTINE Transdermal patch 35 mg 4 4 NICOTINE Transdermal patch 52.5 mg 6 6 NIFEDIPINE Tablet 10 mg 8,065 8,065 NIFEDIPINE Tablet 20 mg 6,394 6,394 NIFEDIPINE Tablet 20 mg (controlled release) 27,540 1 27,541 NIFEDIPINE Tablet 30 mg (controlled release) 56,096 1 56,097 NIFEDIPINE Tablet 60 mg (controlled release) 57,433 1 57,434 NITRAZEPAM Tablet 5 mg 40,632 22 40,654 NITROFURANTOIN Capsule 100 mg 25,910 1 25,911 NITROFURANTOIN Capsule 50 mg 18,043 2 18,045 NIZATIDINE Capsule 150 mg 18,302 1 18,303 NIZATIDINE Capsule 300 mg 19,833 19,833 NORETHISTERONE Tablet 5 mg 69,867 69,867 NORETHISTERONE Tablets 350 micrograms, 28 25,889 25,889
NORETHISTERONE ACETATE + OESTRADIOL
Transdermal patches containing 510 micrograms oestradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8
18,520 18,520
NORETHISTERONE ACETATE + OESTRADIOL
Transdermal patches containing 620 micrograms oestradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8
44,640 44,640
44 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
NORFLOXACIN Tablet 400 mg 55,070 16 55,086 NORTRIPTYLINE Tablet 10 mg (as hydrochloride) 10,692 5 10,697 NORTRIPTYLINE Tablet 25 mg (as hydrochloride) 22,959 4 22,963 NYSTATIN Capsule 500,000 units 10,370 10,370 NYSTATIN Cream 100,000 units per g, 15 g 25 25
NYSTATIN Oral suspension 100,000 units per mL, 24 mL 28,660 75 28,735
NYSTATIN Tablet 500,000 units 6,643 6,643
OCTREOTIDE Injection 100 micrograms (as acetate) in 1 mL 1 1
OESTRADIOL Tablet 2 mg 5,679 5,679
OESTRADIOL Tablet containing oestradiol valerate 1 mg 34,182 1 34,183
OESTRADIOL Tablet containing oestradiol valerate 2 mg 52,659 52,659
OESTRADIOL Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 40,184 40,184
OESTRADIOL Transdermal patches 1.17 mg, 8 17,473 17,473
OESTRADIOL Transdermal patches 1.5 mg (as hemihydrate), 8 17,358 17,358
OESTRADIOL Transdermal patches 1.56 mg, 8 18,372 18,372 OESTRADIOL Transdermal patches 2 mg, 4 8,686 8,686 OESTRADIOL Transdermal patches 2 mg, 8 2,346 2,346
OESTRADIOL Transdermal patches 3 mg (as hemihydrate), 8 6,078 6,078
OESTRADIOL Transdermal patches 3.8 mg, 4 16,828 16,828
OESTRADIOL Transdermal patches 390 micrograms, 8 14,210 14,210
OESTRADIOL Transdermal patches 5.7 mg, 4 5,891 5,891
OESTRADIOL Transdermal patches 585 micrograms, 8 14,626 14,626
OESTRADIOL Transdermal patches 7.6 mg, 4 5,641 5,641
OESTRADIOL Transdermal patches 750 micrograms (as hemihydrate), 8 9,850 9,850
OESTRADIOL Transdermal patches 780 micrograms, 8 43,369 43,369
OESTRADIOL Vaginal tablets 25 micrograms, 15 243,479 243,479
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 45
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
OESTRADIOL (&) NORETHISTERONE ACETATE + OESTRADIOL
Pack containing 4 transdermal patches 780 micrograms oestradiol (as hemihydrate) and 4 transdermal patches 510 micrograms oestradiol (as hemihydrate) with 4.8 mg norethisterone acetate
7,185 7,185
OESTRADIOL (&) NORETHISTERONE ACETATE + OESTRADIOL
Pack containing 4 transdermal patches 780 micrograms oestradiol (as hemihydrate) and 4 transdermal patches 620 micrograms oestradiol (as hemihydrate) with 2.7 mg norethisterone acetate
14,009 14,009
OESTRADIOL (&) OESTRADIOL + DYDROGESTERONE
Pack containing 14 tablets oestradiol 2 mg and 14 tablets oestradiol 2 mg with dydrogesterone 10 mg
10,944 10,944
OESTRIOL Pessaries 500 micrograms, 15 314 314 OESTRIOL Vaginal cream 1 mg per g, 15 g 105,944 105,944 OFLOXACIN Eye drops 3 mg per mL, 5 mL 2,129 2,129 OLANZAPINE Tablet 10 mg 44 44 OLANZAPINE Tablet 2.5 mg 85 85 OLANZAPINE Tablet 5 mg 127 127 OLANZAPINE Tablet 5 mg (as benzoate) 1 1 OLANZAPINE Tablet 5 mg (orally disintegrating) 3 3 OLANZAPINE Tablet 7.5 mg 8 8 OLANZAPINE Wafer 10 mg 11 11 OLANZAPINE Wafer 15 mg 1 1 OLANZAPINE Wafer 5 mg 44 44
OLMESARTAN MEDOXOMIL
Tablet containing olmesartan medoxomil 20 mg 163,371 163,371
OLMESARTAN MEDOXOMIL
Tablet containing olmesartan medoxomil 40 mg 124,309 1 124,310
OLMESARTAN MEDOXOMIL + AMLODIPINE
Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besylate)
17,611 17,611
OLMESARTAN MEDOXOMIL + AMLODIPINE
Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besylate)
4,016 4,016
46 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
OLMESARTAN MEDOXOMIL + AMLODIPINE
Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besylate)
33,159 33,159
OLMESARTAN MEDOXOMIL + HYDROCHLOROTHIAZIDE
Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg
31,808 31,808
OLMESARTAN MEDOXOMIL + HYDROCHLOROTHIAZIDE
Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg
72,829 72,829
OLMESARTAN MEDOXOMIL + HYDROCHLOROTHIAZIDE
Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg
49,884 49,884
OLSALAZINE Capsule containing olsalazine sodium 250 mg 1 1
OMEPRAZOLE Capsule 20 mg 39,195 5 39,200 OMEPRAZOLE Tablet 10 mg (as magnesium) 35,162 3 35,165 OMEPRAZOLE Tablet 20 mg 251,160 121 251,281 OMEPRAZOLE Tablet 20 mg (as magnesium) 340,843 16 340,859
ONDANSETRON I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL 871 871
ONDANSETRON I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL 15,210 51 15,261
ONDANSETRON Tablet (orally disintegrating) 4 mg 2,810 2,810 ONDANSETRON Tablet (orally disintegrating) 8 mg 184 184
ONDANSETRON Tablet 4 mg (as hydrochloride dihydrate) 6,798 6,798
ONDANSETRON Tablet 8 mg (as hydrochloride dihydrate) 11,192 11,192
ONDANSETRON Wafer 4 mg 18,374 18,374 ONDANSETRON Wafer 8 mg 1,792 1,792 OXAZEPAM Tablet 15 mg 42,395 95 42,490 OXAZEPAM Tablet 30 mg 86,460 20 86,480 OXCARBAZEPINE Tablet 150 mg 1 1
OXPRENOLOL Tablet containing oxprenolol hydrochloride 20 mg 754 754
OXPRENOLOL Tablet containing oxprenolol hydrochloride 40 mg 30 1 31
OXYBUTYNIN Tablet containing oxybutynin hydrochloride 5 mg 40,043 5 40,048
OXYBUTYNIN Transdermal patches 36 mg, 8 13,770 13,770
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 47
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
OXYCODONE Capsule containing oxycodone hydrochloride 10 mg 32,950 29 32,979
OXYCODONE Capsule containing oxycodone hydrochloride 20 mg 8,931 8,931
OXYCODONE Capsule containing oxycodone hydrochloride 5 mg 48,967 204 49,171
OXYCODONE Oral solution containing oxycodone hydrochloride 5 mg per 5 mL, 250 mL
6,313 6,313
OXYCODONE Suppository 30 mg (as pectinate) 15 15
OXYCODONE Tablet containing oxycodone hydrochloride 10 mg (controlled release)
70,123 13 70,136
OXYCODONE Tablet containing oxycodone hydrochloride 15 mg (controlled release)
5,844 5,844
OXYCODONE Tablet containing oxycodone hydrochloride 20 mg (controlled release)
3,407 3 3,410
OXYCODONE Tablet containing oxycodone hydrochloride 30 mg (controlled release)
205 3 208
OXYCODONE Tablet containing oxycodone hydrochloride 40 mg (controlled release)
263 3 266
OXYCODONE Tablet containing oxycodone hydrochloride 5 mg 621,552 897 622,449
OXYCODONE Tablet containing oxycodone hydrochloride 5 mg (controlled release)
28,492 23 28,515
OXYCODONE Tablet containing oxycodone hydrochloride 80 mg (controlled release)
53 53
OXYCODONE + NALOXONE
Tablet (controlled release) containing oxycodone hydrochloride 10 mg with naloxone hydrochloride 5 mg
31,332 2 31,334
OXYCODONE + NALOXONE
Tablet (controlled release) containing oxycodone hydrochloride 20 mg with naloxone hydrochloride 10 mg
1,234 1,234
48 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
OXYCODONE + NALOXONE
Tablet (controlled release) containing oxycodone hydrochloride 40 mg with naloxone hydrochloride 20 mg
31 31
OXYCODONE + NALOXONE
Tablet (controlled release) containing oxycodone hydrochloride 5 mg with naloxone hydrochloride 2.5 mg
16,570 5 16,575
PALIPERIDONE Tablet 3 mg (prolonged release) 8 8 PALIPERIDONE Tablet 6 mg (prolonged release) 6 6
PALONOSETRON Injection 250 micrograms (as hydrochloride) in 5 mL 5,956 5,956
PANCREATIC EXTRACT
Capsule (containing enteric coated minimicrospheres) providing not less than 10,000 BP units of lipase activity
53 53
PANCREATIC EXTRACT
Capsule (containing enteric coated minimicrospheres) providing not less than 25,000 BP units of lipase activity
11 11
PANCREATIC EXTRACT
Capsule (containing enteric coated minimicrospheres) providing not less than 40,000 BP units of lipase activity
3 3
PANTOPRAZOLE Sachet containing granules 40 mg (as sodium sesquihydrate) 7,319 7,319
PANTOPRAZOLE Tablet (enteric coated) 20 mg (as sodium sesquihydrate) 163,152 32 163,184
PANTOPRAZOLE Tablet (enteric coated) 40 mg (as sodium sesquihydrate) 975,758 31 975,789
PARACETAMOL Oral liquid 120 mg per 5 mL, 100 mL 1,076 1,076
PARACETAMOL Oral liquid 240 mg per 5 mL, 200 mL 4,781 3 4,784
PARACETAMOL Suppositories 500 mg, 24 8 8 PARACETAMOL Tablet 500 mg 112,621 1,113 113,734 PARACETAMOL Tablet 665 mg (modified release) 236,423 64 236,487
PARACETAMOL + CODEINE Tablet containing codeine phosphate 15 mg with paracetamol 500 mg
1 1
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 49
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
PARACETAMOL + CODEINE Tablet containing codeine phosphate 30 mg with paracetamol 500 mg
1,434,713 332 1,435,045
PARACETAMOL + CODEINE Tablet containing codeine phosphate 8 mg with paracetamol 500 mg
5 5
PARAFFIN Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g
1,062 1,062
PARAFFIN
Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g
6,951 6,951
PARAFFIN + RETINYL PALMITATE
Eye ointment, compound, containing liquid paraffin, light liquid paraffin, wool fat, white soft paraffin and retinyl palmitate, 5 g
107 107
PAROXETINE Tablet 20 mg (as hydrochloride) 384,501 7 384,508 PAROXETINE Tablet 20 mg (as mesilate) 1,505 1,505 PENICILLAMINE Tablet 125 mg 79 79
PENTASTARCH + SODIUM CHLORIDE
I.V. infusion 30 g per 500 mL, 500 mL 186 186
PERHEXILINE Tablet containing perhexiline maleate 100 mg 8 1 9
PERICYAZINE Tablet 10 mg 2,232 2,232 PERICYAZINE Tablet 2.5 mg 6,464 5 6,469
PERINDOPRIL Tablet containing perindopril arginine 10 mg 331,431 14 331,445
PERINDOPRIL Tablet containing perindopril arginine 2.5 mg 145,584 227 145,811
PERINDOPRIL Tablet containing perindopril arginine 5 mg 388,979 28 389,007
PERINDOPRIL Tablet containing perindopril erbumine 2 mg 151,125 21 151,146
PERINDOPRIL Tablet containing perindopril erbumine 4 mg 428,586 428,586
PERINDOPRIL Tablet containing perindopril erbumine 8 mg 359,107 359,107
PERINDOPRIL + INDAPAMIDE
Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg
11,459 11,459
50 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
PERINDOPRIL + INDAPAMIDE
Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg
224,449 1 224,450
PERINDOPRIL + INDAPAMIDE
Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg
243,070 243,070
PERMETHRIN Cream 50 mg per g, 30 g 15,526 15,526 PHENELZINE Tablet 15 mg (as sulfate) 1 1
PHENOBARBITONE Injection 200 mg (as sodium) in 1 mL 5 5
PHENOBARBITONE Injection containing phenobarbitone sodium 200 mg in 1 mL
3 3
PHENOBARBITONE Tablet 30 mg 2,188 2,188
PHENOXYBENZAMINE Capsule containing phenoxybenzamine hydrochloride 10 mg
1 1
PHENOXYMETHYLPENICILLIN Capsule 250 mg phenoxymethylpenicillin (as potassium)
30,209 1 30,210
PHENOXYMETHYLPENICILLIN Capsule 500 mg phenoxymethylpenicillin (as potassium)
189,727 1 189,728
PHENOXYMETHYLPENICILLIN Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL 70,986 70,986
PHENOXYMETHYLPENICILLIN Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL 4,347 4,347
PHENOXYMETHYLPENICILLIN Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL 19,503 19,503
PHENOXYMETHYLPENICILLIN Tablet 250 mg phenoxymethylpenicillin (as potassium)
14,225 14,225
PHENOXYMETHYLPENICILLIN Tablet 500 mg phenoxymethylpenicillin (as potassium)
55,723 55,723
PHENYLEPHRINE + PREDNISOLONE ACETATE
Eye drops containing prednisolone acetate 10 mg with phenylephrine hydrochloride 1.2 mg per mL, 10 mL
92,439 92,439
PHENYTOIN Capsule containing phenytoin sodium 100 mg 32,947 7 32,954
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 51
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
PHENYTOIN Capsule containing phenytoin sodium 30 mg 3,884 2 3,886
PHENYTOIN Oral suspension 30 mg per 5 mL, 500 mL 428 428
PHENYTOIN Tablet 50 mg 36 36 PHOLCODINE Linctus 1mg per mL (0.1%), 100 mL 1 1
PHOSPHORUS Tablet, compound effervescent, equivalent to 500 mg phosphorus 25 25
PILOCARPINE Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL
1,806 1,806
PILOCARPINE Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL
2,499 2,499
PILOCARPINE Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL
1,121 1,121
PIMECROLIMUS Cream 10 mg per g, 15 g 16,678 16,678 PINDOLOL Tablet 15 mg 2,308 2,308 PINDOLOL Tablet 5 mg 1,244 1,244 PIOGLITAZONE Tablet 15 mg (as hydrochloride) 76 76 PIOGLITAZONE Tablet 30 mg (as hydrochloride) 2 2 PIOGLITAZONE Tablet 45 mg (as hydrochloride) 2 2 PIROXICAM Capsule 10 mg 7,548 7,548 PIROXICAM Capsule 20 mg 38,679 38,679 PIROXICAM Dispersible tablet 10 mg 875 875 PIROXICAM Dispersible tablet 20 mg 17,285 17,285 PIZOTIFEN Tablet 500 micrograms (as malate) 44,931 44,931 PODOPHYLLUM RESIN Paint 25mL 2 2
POLYETHYLENE GLYCOL-400 Eye drops 2.5 mg per mL, 15 mL 367 12 379
POLYETHYLENE GLYCOL-400
Eye drops 2.5 mg per mL, single dose units 0.4 mL, 20 7 7
POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL
Eye drops 4 mg-3 mg per mL, 15 mL 10,411 55 10,466
POLYETHYLENE GLYCOL-400 + PROPYLENE GLYCOL
Eye drops 4 mg-3 mg per mL, single dose units 0.8 mL, 28 1,369 1,369
POLYVINYL ALCOHOL Eye drops 14 mg per mL, 15 mL 1,511 9 1,520
52 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
POLYVINYL ALCOHOL
Eye drops 14 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative)
222 14 236
POLYVINYL ALCOHOL Eye drops 30 mg per mL, 15 mL 476 476
POLYVINYL ALCOHOL
Eye drops 30 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative)
46 46
POTASSIUM CHLORIDE Tablet 600 mg (sustained release) 41,186 205 41,391
POTASSIUM CHLORIDE + POTASSIUM BICARBONATE + POTASSIUM CARBONATE
Tablet, effervescent, 14 mmol potassium and 8 mmol chloride 3,960 25 3,985
PRAMIPEXOLE Tablet (extended release) containing pramipexole hydrochloride 1.5 mg
1 1
PRAMIPEXOLE Tablet (extended release) containing pramipexole hydrochloride 375 micrograms
2,540 1 2,541
PRAMIPEXOLE Tablet (extended release) containing pramipexole hydrochloride 750 micrograms
4,135 4,135
PRAMIPEXOLE Tablet containing pramipexole hydrochloride 1 mg 2 2
PRAMIPEXOLE Tablet containing pramipexole hydrochloride 125 micrograms 12,123 4 12,127
PRAMIPEXOLE Tablet containing pramipexole hydrochloride 250 micrograms 6,389 3 6,392
PRASUGREL Tablet 10 mg (as hydrochloride) 2 2
PRAVASTATIN Tablet containing pravastatin sodium 10 mg 15,048 15,048
PRAVASTATIN Tablet containing pravastatin sodium 20 mg 43,483 43,483
PRAVASTATIN Tablet containing pravastatin sodium 40 mg 82,151 8 82,159
PRAVASTATIN Tablet containing pravastatin sodium 80 mg 24,130 24,130
PRAZIQUANTEL Tablet 600 mg 47 47 PRAZOSIN Tablet 1 mg (as hydrochloride) 51,258 61 51,319 PRAZOSIN Tablet 2 mg (as hydrochloride) 27,212 4 27,216 PRAZOSIN Tablet 5 mg (as hydrochloride) 18,511 18,511
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 53
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
PREDNISOLONE Tablet 1 mg 54,910 49 54,959 PREDNISOLONE Tablet 25 mg 394,549 323 394,872 PREDNISOLONE Tablet 5 mg 240,037 386 240,423
PREDNISOLONE SODIUM PHOSPHATE
Enema, retention, 20 mg (as sodium phosphate) in 100 mL 3 3
PREDNISOLONE SODIUM PHOSPHATE
Oral solution 5 mg (as sodium phosphate) per mL, 30 mL 307,149 307,149
PREDNISOLONE SODIUM PHOSPHATE
Suppositories 5 mg (as sodium phosphate), 10 493 493
PREDNISONE Tablet 1 mg 24,436 5 24,441 PREDNISONE Tablet 25 mg 126,231 126,231 PREDNISONE Tablet 5 mg 88,572 20 88,592 PREGABALIN Capsule 150 mg 50 50 PREGABALIN Capsule 25 mg 4,112 2 4,114 PREGABALIN Capsule 300 mg 2 2 PREGABALIN Capsule 75 mg 179 1 180 PRIMIDONE Tablet 250 mg 13 1 14 PROBENECID Tablet 500 mg 481 3 484
PROCAINE PENICILLIN Injection 1.5 g in disposable syringe 21 21
PROCHLORPERAZINE Injection containing prochlorperazine mesylate 12.5 mg in 1 mL
1,066 1,066
PROCHLORPERAZINE Suppositories containing prochlorperazine equivalent to 25 mg prochlorperazine maleate, 5
6,287 6,287
PROCHLORPERAZINE Tablet containing prochlorperazine maleate 5 mg 233,507 62 233,569
PROMETHAZINE Injection containing promethazine hydrochloride 50 mg in 2 mL 1,449 1,449
PROPANTHELINE Tablet containing propantheline bromide 15 mg 3,227 3,227
PROPRANOLOL Tablet containing propranolol hydrochloride 10 mg 71,202 31 71,233
PROPRANOLOL Tablet containing propranolol hydrochloride 160 mg 8,296 8,296
PROPRANOLOL Tablet containing propranolol hydrochloride 40 mg 109,516 31 109,547
PROPYLTHIOURACIL Tablet 50 mg 314 314
54 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
PROTEIN HYDROLYSATE FORMULA with MEDIUM CHAIN TRIGLYCERIDES
Oral powder 400 g (Alfare) 4 4
PROTEIN HYDROLYSATE FORMULA with MEDIUM CHAIN TRIGLYCERIDES
Oral powder 450 g (Karicare Aptamil Pepti-Junior Gold) 14 14
PYRANTEL Tablet 125 mg (as embonate) 99 99 PYRANTEL Tablet 250 mg (as embonate) 356 356
PYRIDOSTIGMINE Tablet containing pyridostigmine bromide 10 mg 592 592
PYRIDOSTIGMINE Tablet containing pyridostigmine bromide 60 mg 5 5
PYRIMETHAMINE Tablet 25 mg 85 85
QUETIAPINE Tablet (modified release) 150 mg (as fumarate) 11 11
QUETIAPINE Tablet (modified release) 200 mg (as fumarate) 58 58
QUETIAPINE Tablet (modified release) 300 mg (as fumarate) 19 19
QUETIAPINE Tablet (modified release) 400 mg (as fumarate) 11 11
QUETIAPINE Tablet (modified release) 50 mg (as fumarate) 126 126
QUETIAPINE Tablet 100 mg (as fumarate) 381 381 QUETIAPINE Tablet 200 mg (as fumarate) 102 102 QUETIAPINE Tablet 25 mg (as fumarate) 1,199 2 1,201 QUETIAPINE Tablet 300 mg (as fumarate) 27 27
QUINAGOLIDE
Pack containing 3 tablets quinagolide 25 micrograms (as hydrochloride) and 3 tablets quinagolide 50 micrograms (as hydrochloride)
19 19
QUINAPRIL Tablet 10 mg (as hydrochloride) 19,072 1 19,073 QUINAPRIL Tablet 20 mg (as hydrochloride) 39,829 39,829 QUINAPRIL Tablet 5 mg (as hydrochloride) 6,673 1 6,674
QUINAPRIL + HYDROCHLOROTHIAZIDE
Tablet 10 mg quinapril (as hydrochloride) with 12.5 mg hydrochlorothiazide
4,960 4,960
QUINAPRIL + HYDROCHLOROTHIAZIDE
Tablet 20 mg quinapril (as hydrochloride) with 12.5 mg hydrochlorothiazide
27,262 27,262
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 55
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
QUININE Tablet containing quinine sulfate 300 mg 307 307
RABEPRAZOLE Tablet containing rabeprazole sodium 10 mg (enteric coated) 25,947 1 25,948
RABEPRAZOLE Tablet containing rabeprazole sodium 20 mg (enteric coated) 678,338 5 678,343
RALOXIFENE Tablet containing raloxifene hydrochloride 60 mg 4 4
RAMIPRIL Capsule 1.25 mg 3,995 12 4,007 RAMIPRIL Capsule 10 mg 385,046 3 385,049 RAMIPRIL Capsule 2.5 mg 18,539 46 18,585 RAMIPRIL Capsule 5 mg 31,516 15 31,531
RAMIPRIL Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg
346 346
RAMIPRIL Tablet 1.25 mg 39,578 67 39,645 RAMIPRIL Tablet 10 mg 83,884 2 83,886 RAMIPRIL Tablet 2.5 mg 144,763 117 144,880 RAMIPRIL Tablet 5 mg 269,348 41 269,389
RAMIPRIL + FELODIPINE Tablet 2.5 mg-2.5 mg (modified release) 3,176 3,176
RAMIPRIL + FELODIPINE Tablet 5 mg-5 mg (modified release) 29,438 29,438
RANITIDINE Syrup 150 mg (as hydrochloride) per 10 mL, 300 mL 13,404 13,404
RANITIDINE Tablet 150 mg (as hydrochloride) 85,385 11 85,396 RANITIDINE Tablet 300 mg (as hydrochloride) 56,943 56,943
RANITIDINE Tablet, effervescent, 150 mg (as hydrochloride) 8,153 8,153
RASAGILINE Tablet 1 mg (as mesilate) 1 1 REBOXETINE Tablet 4 mg (as mesilate) 260 1 261
RHAMNUS FRANGULA + STERCULIA
Granules 620 mg-80 mg per g, 500 g 1,093 1,093
RIFAMPICIN Capsule 150 mg 5 5 RIFAMPICIN Capsule 300 mg 719 719 RIFAMPICIN Syrup 100 mg per 5 mL, 60 mL 87 87
RISEDRONATE Tablet (enteric coated) containing risedronate sodium 35 mg 22 22
56 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
RISEDRONATE Tablet containing risedronate sodium 150 mg 50 50
RISEDRONATE Tablet containing risedronate sodium 35 mg 1 1
RISEDRONATE (&) CALCIUM CARBONATE
Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate)
2 2
RISPERIDONE Tablet 0.5 mg 10,411 17 10,428
RISPERIDONE Tablet 0.5 mg (orally disintegrating) 2,332 5 2,337
RISPERIDONE Tablet 1 mg 643 1 644 RISPERIDONE Tablet 1 mg (orally disintegrating) 210 210 RISPERIDONE Tablet 2 mg 177 177 RISPERIDONE Tablet 2 mg (orally disintegrating) 76 76 RISPERIDONE Tablet 3 mg 85 85 RISPERIDONE Tablet 3 mg (orally disintegrating) 33 33 RISPERIDONE Tablet 4 mg 27 27 RISPERIDONE Tablet 4 mg (orally disintegrating) 10 10 RITONAVIR Tablet 100 mg 7 7 RIVAROXABAN Tablet 10 mg 53 53 RIVAROXABAN Tablet 15 mg 1 1 RIVASTIGMINE Transdermal patch 9 mg 1 1 RIZATRIPTAN Wafer 10 mg (as benzoate) 81,916 81,916 ROSUVASTATIN Tablet 10 mg (as calcium) 305 1 306 ROSUVASTATIN Tablet 20 mg (as calcium) 43 43 ROSUVASTATIN Tablet 40 mg (as calcium) 13 13 ROSUVASTATIN Tablet 5 mg (as calcium) 224,946 224,946 ROXITHROMYCIN Tablet 150 mg 390,011 27 390,038 ROXITHROMYCIN Tablet 300 mg 543,508 105 543,613 ROXITHROMYCIN Tablet for oral suspension 50 mg 36,254 36,254
SALBUTAMOL
Capsule containing powder for oral inhalation 200 micrograms (as sulfate) (for use in Ventolin Rotahaler)
250 250
SALBUTAMOL Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30
15,359 13 15,372
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 57
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
SALBUTAMOL Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 37,788 23 37,811
SALBUTAMOL Nebuliser solution 5 mg (as sulfate) per mL, 30 mL 27 27
SALBUTAMOL Oral solution 2 mg (as sulfate) per 5 mL, 150 mL 9,191 9,191
SALBUTAMOL Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
636,940 113 637,053
SALBUTAMOL
Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
391 391
SALICYLIC ACID Ointment 100g 291 291 SALICYLIC ACID Paint 25mL 16 16
SALICYLIC ACID with SULPHUR Cream 100g 281 281
SALIVA SUBSTITUTE Eye drops containing carmellose sodium 10 mg per mL, 15 mL 2,912 7 2,919
SALIVA SUBSTITUTE Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30
125 125
SALIVA SUBSTITUTE Eye drops containing carmellose sodium 2.5 mg per mL, single dose units 0.6 mL, 24
340 340
SALIVA SUBSTITUTE Eye drops containing carmellose sodium 5 mg per mL, 15 mL 6,930 50 6,980
SALIVA SUBSTITUTE Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30
379 379
SALIVA SUBSTITUTE Mouth spray containing carmellose sodium 10 mg per mL, 100 mL 12 2 14
SALIVA SUBSTITUTE Mouth spray containing carmellose sodium 10 mg per mL, 25 mL 3 1 4
SALIVA SUBSTITUTE Ocular lubricating gel containing carmellose sodium 10 mg per mL, single dose units 0.6 mL, 28
629 629
SALMETEROL
Powder for oral inhalation in breath actuated device 50 micrograms (as xinafoate) per dose, 60 doses
90 90
58 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
SELEGILINE Tablet containing selegiline hydrochloride 5 mg 3 3
SENNOSIDE B Tablet 7.5 mg 4 4 SERTRALINE Tablet 100 mg (as hydrochloride) 714,559 11 714,570 SERTRALINE Tablet 50 mg (as hydrochloride) 678,702 17 678,719 SIMVASTATIN Tablet 10 mg 64,664 4 64,668 SIMVASTATIN Tablet 20 mg 214,911 14 214,925 SIMVASTATIN Tablet 40 mg 328,755 12 328,767 SIMVASTATIN Tablet 5 mg 5,028 5,028 SIMVASTATIN Tablet 80 mg 90,116 1 90,117
SITAGLIPTIN Tablet 100 mg (as phosphate monohydrate) 8 8
SITAGLIPTIN Tablet 50 mg (as phosphate monohydrate) 1 1
SITAGLIPTIN + METFORMIN
Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride
9 9
SODIUM BICARBONATE Sodi bicarb ear drop 15mL 1,072 1,072 SODIUM CHLORIDE I.V. infusion 154 mmol per L, 1 L 6,608 6,608
SODIUM CHLORIDE I.V. infusion 38.5 mmol per 250 mL, 250 mL 504 504
SODIUM CHLORIDE I.V. infusion 513 mmol per L, 1 L 42 42
SODIUM CHLORIDE I.V. infusion 77 mmol per 500 mL, 500 mL 336 336
SODIUM CHLORIDE Injection 9 mg per mL, 10 mL 34 6 40
SODIUM CHLORIDE + GLUCOSE
I.V. infusion 31 mmol-222 mmol (anhydrous) per L, 1 L 171 171
SODIUM CHLORIDE + POTASSIUM CHLORIDE + CALCIUM CHLORIDE DIHYDRATE
I.V. infusion containing approximately 148 mmol sodium (as chloride), 4 mmol potassium (as chloride), 2 mmol calcium (as chloride) and 156 mmol chloride per L, 1 L
5 5
SODIUM CHLORIDE + POTASSIUM CHLORIDE + GLUCOSE MONOHYDRATE + CITRATE
Oral rehydration salts containing glucose 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10
1,681 1,681
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 59
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
SODIUM GLUCONATE + SODIUM CHLORIDE + POTASSIUM CHLORIDE + MAGNESIUM CHLORIDE + SODIUM ACETATE TRIHYDRATE + GLUCOSE
Electrolyte replacement solution containing sodium chloride 5.26 g, sodium acetate 3.68 g, sodium gluconate 5.02 g, potassium chloride 370 mg and magnesium chloride 300 mg per L, 1 L
53 53
SODIUM HYALURONATE Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL 257 257
SODIUM HYALURONATE Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL 233 233
SORBITOL + CITRATE + LAURYL SULFOACETATE SODIUM
Enemas 3.125 g-450 mg-45 mg in 5 mL, 12 2,072 2,072
SORBITOL + CITRATE + LAURYL SULFOACETATE SODIUM
Enemas 3.125 g-450 mg-45 mg in 5 mL, 4 3 3
SOTALOL Tablet containing sotalol hydrochloride 160 mg 19,721 19,721
SOTALOL Tablet containing sotalol hydrochloride 80 mg 92,307 47 92,354
SOY LECITHIN + TOCOPHEROLS + VITAMIN A
Eye spray 10 mg per mL, 10 mL 18 18
SPIRIT Spirit ear drop 15mL 135 135 SPIRONOLACTONE Tablet 100 mg 33,056 33,056 SPIRONOLACTONE Tablet 25 mg 64,258 158 64,416
STANDARD FORMULA PREPARATION Aluminium acetate ear drops 18 18
STANDARD FORMULA PREPARATION Benzoic acid compound ointment 43 43
STANDARD FORMULA PREPARATION
Boric acid olive oil and zinc oxide ointment 35 35
STANDARD FORMULA PREPARATION Menthol inhaations 50mL 26 26
STANDARD FORMULA PREPARATION Salicylic acid ointment 163 163
STRONTIUM Sachet containing granules for oral suspension containing strontium ranelate 2 g
11 11
SUCRALFATE Tablet equivalent to 1 g anhydrous sucralfate 3,483 3,483
60 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
SULFADIAZINE SILVER Cream 10 mg per g, 50 g 23,067 23,067 SULFASALAZINE Tablet 500 mg 586 4 590 SULFASALAZINE Tablet 500 mg (enteric coated) 938 938 SULTHIAME Tablet 50 mg 1 1
SUMATRIPTAN Nasal spray 20 mg in 0.1 mL single dose unit 37,691 37,691
SUMATRIPTAN Tablet (fast disintegrating) 50 mg (as succinate) 24,307 24,307
SUMATRIPTAN Tablet 50 mg (as succinate) 140,757 140,757 TACROLIMUS Capsule 0.5 mg 11 11 TAMOXIFEN Tablet 10 mg (as citrate) 121 121 TAMOXIFEN Tablet 20 mg (as citrate) 502 2 504
TAMSULOSIN Tablet 400 micrograms (prolonged release) 1 1 2
TELMISARTAN Tablet 40 mg 570,671 11 570,682 TELMISARTAN Tablet 80 mg 467,777 467,777
TELMISARTAN + AMLODIPINE Tablet 40 mg-10 mg (as besylate) 6,598 6,598
TELMISARTAN + AMLODIPINE Tablet 40 mg-5 mg (as besylate) 33,556 33,556
TELMISARTAN + AMLODIPINE Tablet 80 mg-10 mg (as besylate) 6,524 6,524
TELMISARTAN + AMLODIPINE Tablet 80 mg-5 mg (as besylate) 58,930 58,930
TELMISARTAN + HYDROCHLOROTHIAZIDE Tablet 40 mg-12.5 mg 106,636 106,636
TELMISARTAN + HYDROCHLOROTHIAZIDE Tablet 80 mg-12.5 mg 341,015 341,015
TELMISARTAN + HYDROCHLOROTHIAZIDE Tablet 80 mg-25 mg 100,395 100,395
TEMAZEPAM Tablet 10 mg 516,463 267 516,730
TERBINAFINE Cream containing terbinafine hydrochloride 10 mg per g, 15 g 16 16
TERBINAFINE Tablet 250 mg (as hydrochloride) 3 3
TERBUTALINE Injection containing terbutaline sulfate 500 micrograms in 1 mL 16 16
TERBUTALINE
Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 200 doses
49,429 49,429
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 61
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
TESTOSTERONE ENANTHATE
Injection containing testosterone enanthate 250 mg in 1 mL 7,885 7,885
TESTOSTERONE UNDECANOATE
Capsule containing testosterone undecanoate 40 mg 47 47
TETRABENAZINE Tablet 25 mg 1 1
TETRACOSACTRIN Compound depot injection 1 mg in 1 mL 11 11
THEOPHYLLINE Oral solution 133.3 mg per 25 mL, 500 mL 1,454 1,454
THEOPHYLLINE Tablet 200 mg (sustained release) 1,939 2 1,941 THEOPHYLLINE Tablet 250 mg (sustained release) 2,650 2,650 THEOPHYLLINE Tablet 300 mg (sustained release) 2,082 2,082
THIAMINE Tablet containing thiamine hydrochloride 100 mg 761 49 810
THYMOL Thymol mouth wash white 200m 115 115
THYROXINE Tablet containing 100 micrograms anhydrous thyroxine sodium 253,381 24 253,405
THYROXINE Tablet containing 200 micrograms anhydrous thyroxine sodium 27,942 2 27,944
THYROXINE Tablet containing 50 micrograms anhydrous thyroxine sodium 242,975 40 243,015
THYROXINE Tablet containing 75 micrograms anhydrous thyroxine sodium 76,569 3 76,572
TIAPROFENIC ACID Tablet 300 mg 902 902 TICAGRELOR Tablet 90 mg 5 5
TICARCILLIN + CLAVULANIC ACID
Powder for injection containing ticarcillin 3 g (as sodium) with 100 mg clavulanic acid (as potassium clavulanate)
187 187
TICLOPIDINE Tablet containing ticlopidine hydrochloride 250 mg 1 1
TIMOLOL Eye drops (gellan gum solution) 2.5 mg (as maleate) per mL, 2.5 mL 3,072 3,072
TIMOLOL Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL 15,596 2 15,598
TIMOLOL Eye drops 2.5 mg (as maleate) per mL, 5 mL 4,027 2 4,029
TIMOLOL Eye drops 5 mg (as maleate) per mL, 5 mL 25,325 12 25,337
TIMOLOL Eye gel 1 mg (as maleate) per g, 5 g 8,920 8,920
62 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
TINIDAZOLE Tablet 500 mg 77,122 2 77,124
TIOTROPIUM
Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in HandiHaler)
49 49
TOBRAMYCIN Eye drops 3 mg per mL, 5 mL 26,057 26,057 TOBRAMYCIN Eye ointment 3 mg per g, 3.5 g 7,702 7,702 TOBRAMYCIN Injection 80 mg (as sulfate) in 2 mL 31 31
TOBRAMYCIN Injection 80 mg (as sulfate) in 2 mL (without preservative) 12 12
TOPIRAMATE Capsule 15 mg 163 163 TOPIRAMATE Capsule 25 mg 89 89 TOPIRAMATE Tablet 100 mg 17 17 TOPIRAMATE Tablet 200 mg 1 1 TOPIRAMATE Tablet 25 mg 282 282 TOPIRAMATE Tablet 50 mg 4 4
TRAMADOL Capsule containing tramadol hydrochloride 50 mg 343,215 231 343,446
TRAMADOL Injection containing tramadol hydrochloride 100 mg in 2 mL 1,471 1,471
TRAMADOL Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL
877 877
TRAMADOL Tablet (extended release) containing tramadol hydrochloride 100 mg
2,691 2,691
TRAMADOL Tablet (extended release) containing tramadol hydrochloride 200 mg
3,343 3,343
TRAMADOL Tablet (extended release) containing tramadol hydrochloride 300 mg
1,951 1,951
TRAMADOL Tablet (sustained release) containing tramadol hydrochloride 100 mg
113,603 19 113,622
TRAMADOL Tablet (sustained release) containing tramadol hydrochloride 150 mg
45,016 2 45,018
TRAMADOL Tablet (sustained release) containing tramadol hydrochloride 200 mg
69,154 1 69,155
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 63
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
TRAMADOL Tablet (sustained release) containing tramadol hydrochloride 50 mg
34,520 7 34,527
TRANDOLAPRIL Capsule 1 mg 12,126 2 12,128 TRANDOLAPRIL Capsule 2 mg 26,329 26,329 TRANDOLAPRIL Capsule 4 mg 31,330 31,330 TRANDOLAPRIL Capsule 500 micrograms 3,157 3,157
TRANDOLAPRIL + VERAPAMIL
Tablet containing trandolapril 2 mg with verapamil hydrochloride 180 mg (sustained release)
4,098 4,098
TRANDOLAPRIL + VERAPAMIL
Tablet containing trandolapril 4 mg with verapamil hydrochloride 240 mg (sustained release)
20,635 20,635
TRANEXAMIC ACID Tablet 500 mg 1,206 1,206 TRANYLCYPROMINE Tablet 10 mg (as sulfate) 2,038 2,038
TRAVOPROST Eye drops 40 micrograms per mL, 2.5 mL 35 35
TRIAMCINOLONE Cream containing triamcinolone acetonide 200 micrograms per g, 100 g
58,731 58,731
TRIAMCINOLONE Injection containing triamcinolone acetonide 10 mg in 1 mL 7,309 1 7,310
TRIAMCINOLONE Ointment containing triamcinolone acetonide 200 micrograms per g, 100 g
18,365 1 18,366
TRIAMCINOLONE + NEOMYCIN SULFATE + GRAMICIDIN + NYSTATIN
Ear drops containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 7.5 mL
75,184 5 75,189
TRIAMCINOLONE + NEOMYCIN SULFATE + GRAMICIDIN + NYSTATIN
Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g
109,330 46 109,376
TRIFLUOPERAZINE Tablet 1 mg (as hydrochloride) 1,369 1,369 TRIFLUOPERAZINE Tablet 2 mg (as hydrochloride) 901 901 TRIFLUOPERAZINE Tablet 5 mg (as hydrochloride) 1,259 1,259
TRIGLYCERIDES MEDIUM CHAIN Oil 500 mL (MCT Oil) 4 4
64 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
TRIGLYCERIDES MEDIUM CHAIN Oral emulsion 250 mL (Liquigen) 5 5
TRIGLYCERIDES MEDIUM CHAIN and LONG CHAIN with GLUCOSE POLYMER
Oral powder 400 g (Duocal) 1 1
TRIMETHOPRIM Tablet 300 mg 351,285 460 351,745
TRIMETHOPRIM + SULFAMETHOXAZOLE
Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL 63,774 7 63,781
TRIMETHOPRIM + SULFAMETHOXAZOLE Tablet 160 mg-800 mg 169,793 150 169,943
TROPISETRON Capsule 5 mg (as hydrochloride) 309 309
TROPISETRON I.V. injection 5 mg (as hydrochloride) in 5 mL 5,677 5,677
UREA Cream 100 mg per g (10%), 100 g 8 8 VALACICLOVIR Tablet 500 mg (as hydrochloride) 18 18
VALPROATE Oral liquid containing sodium valproate 200 mg per 5 mL, 300 mL 4,634 4,634
VALPROATE Oral solution containing sodium valproate 200 mg per 5 mL, 300 mL 1,336 1,336
VALPROATE Tablet (enteric coated) containing sodium valproate 200 mg 70,415 8 70,423
VALPROATE Tablet (enteric coated) containing sodium valproate 500 mg 3,979 5 3,984
VALPROATE Tablet, crushable, containing sodium valproate 100 mg 7,481 1 7,482
VALSARTAN Tablet 160 mg 21,773 21,773 VALSARTAN Tablet 320 mg 7,434 1 7,435 VALSARTAN Tablet 40 mg 1,309 2 1,311 VALSARTAN Tablet 80 mg 29,970 1 29,971
VALSARTAN + HYDROCHLOROTHIAZIDE Tablet 160 mg-12.5 mg 7,127 7,127
VALSARTAN + HYDROCHLOROTHIAZIDE Tablet 160 mg-25 mg 2,886 2,886
VALSARTAN + HYDROCHLOROTHIAZIDE Tablet 320 mg-12.5 mg 4,545 4,545
VALSARTAN + HYDROCHLOROTHIAZIDE Tablet 320 mg-25 mg 3,936 3,936
VALSARTAN + HYDROCHLOROTHIAZIDE Tablet 80 mg-12.5 mg 4,447 4,447
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13 65
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
VANCOMYCIN Capsule 125 mg (125,000 I.U.) (as hydrochloride) 3 3
VANCOMYCIN Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) 3,371 3,371
VANCOMYCIN Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) 3,172 3,172
VARENICLINE
Box containing 11 tablets 0.5 mg (as tartrate) and 14 tablets 1 mg (as tartrate) in the first pack and 28 tablets 1 mg (as tartrate) in the second pack
1 1
VARENICLINE Tablet 1 mg (as tartrate) 82 82
VENLAFAXINE Capsule (modified release) 150 mg (as hydrochloride) 1,129 1,129
VENLAFAXINE Capsule (modified release) 37.5 mg (as hydrochloride) 63,380 5 63,385
VENLAFAXINE Capsule (modified release) 75 mg (as hydrochloride) 4,140 6 4,146
VERAPAMIL Capsule containing verapamil hydrochloride 160 mg (sustained release)
13,134 6 13,140
VERAPAMIL Capsule containing verapamil hydrochloride 240 mg (sustained release)
21,213 2 21,215
VERAPAMIL Injection containing verapamil hydrochloride 5 mg in 2 mL 3 3
VERAPAMIL Tablet containing verapamil hydrochloride 120 mg 1,441 1,441
VERAPAMIL Tablet containing verapamil hydrochloride 160 mg 551 551
VERAPAMIL Tablet containing verapamil hydrochloride 180 mg (sustained release)
54,281 1 54,282
VERAPAMIL Tablet containing verapamil hydrochloride 240 mg (sustained release)
107,716 2 107,718
VERAPAMIL Tablet containing verapamil hydrochloride 40 mg 6,985 6 6,991
VERAPAMIL Tablet containing verapamil hydrochloride 80 mg 5,186 1 5,187
VILDAGLIPTIN Tablet 50 mg 1 1
66 REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
DRUG NAME FORM STRENGTH Prescription
Numbers PBS
Prescription Numbers
RPBS
Prescription Numbers
TOTALS
VILDAGLIPTIN + METFORMIN
Tablet containing 50 mg vildagliptin with 1000 mg metformin hydrochloride
2 2
WARFARIN Tablet containing warfarin sodium 1 mg 189,008 338 189,346
WARFARIN Tablet containing warfarin sodium 2 mg 152,642 112 152,754
WARFARIN Tablet containing warfarin sodium 3 mg 68,195 145 68,340
WARFARIN Tablet containing warfarin sodium 5 mg 199,754 17 199,771
ZINC COMPOUND Pst 100g 24 24
ZINC with STARCH with TALC Powder 10 10
ZIPRASIDONE Capsule 20 mg (as hydrochloride) 12 12 ZIPRASIDONE Capsule 40 mg (as hydrochloride) 6 6 ZIPRASIDONE Capsule 60 mg (as hydrochloride) 3 3 ZIPRASIDONE Capsule 80 mg (as hydrochloride) 1 1 ZOLMITRIPTAN Tablet 2.5 mg 49,670 49,670 ZONISAMIDE Capsule 25 mg 231 231 ZONISAMIDE Capsule 50 mg 470 470 ZOPICLONE Tablet 7.5 mg 15 15 ZUCLOPENTHIXOL DECANOATE Oily I.M. injection 200 mg in 1 mL 1,408 1,408
OTHER RPBS unlisted items 3,632 3,632
Grand Total 62,051,586 23,367 62,074,953
REPORT TO PARLIAMENT ON THE COLLECTION OF PBS/RPBS UNDER CO-PAYMENT PRESCRIPTION DATA 2012-13
1058
3 A
pril
2014
www.health.gov.auAll informati on in this publicati on is correct as at April 2014